| American College of Mohs Surgery | 86.1 | 3 | 3 |
| Mayo Clinic | 60.0 | 4 | 0 |
| Cleveland Clinic | 60.0 | 4 | 0 |
| National Institute for Occupational Safety and Health | 51.7 | 3 | 0 |
| The Cigna Group | 51.7 | 3 | 0 |
| Vital and health statistics. Series 21, Data on natality, marriage, and divorce | 51.7 | 3 | 0 |
| Vital and health statistics. Series 5, Comparative international vital and health statistics reports | 51.7 | 3 | 0 |
| Office of Readiness and Response | 51.7 | 3 | 0 |
| Clinical trial NCT07597382 | 51.7 | 3 | 0 |
| Clinical trial NCT07585825 | 51.7 | 3 | 0 |
| Clinical trial NCT07571616 | 51.7 | 3 | 0 |
| Clinical trial NCT07571629 | 51.7 | 3 | 0 |
| Clinical trial NCT07611032 | 51.7 | 3 | 0 |
| Skin Cancer Foundation | 43.1 | 1 | 1 |
| Schweiger Dermatology Group (United States) | 43.1 | 1 | 1 |
| Stanford University | 41.0 | 2 | 0 |
| University of Pennsylvania | 41.0 | 2 | 0 |
| Massachusetts General Hospital | 41.0 | 2 | 0 |
| Nucleic Acids Research | 41.0 | 2 | 0 |
| Duke University | 41.0 | 2 | 0 |
| Q229883 | 41.0 | 2 | 0 |
| National Cancer Institute | 41.0 | 2 | 0 |
| U.S. News & World Report | 41.0 | 2 | 0 |
| The University of Texas MD Anderson Cancer Center | 41.0 | 2 | 0 |
| Epi Info | 41.0 | 2 | 0 |
| University of Texas Southwestern Medical Center | 41.0 | 2 | 0 |
| Wojciech Kopczuk | 41.0 | 2 | 0 |
| American Journal of Translational Research | 41.0 | 2 | 0 |
| Biomedical Optics Express | 41.0 | 2 | 0 |
| ClinicalTrials.gov | 41.0 | 2 | 0 |
| dbSNP | 41.0 | 2 | 0 |
| Harvard T.H. Chan School of Public Health | 41.0 | 2 | 0 |
| H. Lee Moffitt Cancer Center & Research Institute | 41.0 | 2 | 0 |
| Northwell Health | 41.0 | 2 | 0 |
| Preventing Chronic Disease | 41.0 | 2 | 0 |
| Saint Luke's Hospital | 41.0 | 2 | 0 |
| Western Journal of Medicine | 41.0 | 2 | 0 |
| Trends in Amplification | 41.0 | 2 | 0 |
| Ulster Medical Journal | 41.0 | 2 | 0 |
| University of Pittsburgh Medical Center | 41.0 | 2 | 0 |
| UpToDate | 41.0 | 2 | 0 |
| Wexner Medical Center at Ohio State University | 41.0 | 2 | 0 |
| The AAPS Journal | 41.0 | 2 | 0 |
| Rice | 41.0 | 2 | 0 |
| AAPS PharmSciTech | 41.0 | 2 | 0 |
| International Journal of Mental Health Systems | 41.0 | 2 | 0 |
| Journal of Urban Health | 41.0 | 2 | 0 |
| Neural Development | 41.0 | 2 | 0 |
| Journal of the Society of Laparoendoscopic Surgeons | 41.0 | 2 | 0 |
| HealthGrades | 41.0 | 2 | 0 |
| National Survey of Family Growth | 41.0 | 2 | 0 |
| National Vital Statistics System | 41.0 | 2 | 0 |
| NIOSH Power Tools Database | 41.0 | 2 | 0 |
| UCLA Health System | 41.0 | 2 | 0 |
| Q20641742 | 41.0 | 2 | 0 |
| Oregon Graduate Center | 41.0 | 2 | 0 |
| Morbidity and Mortality Weekly Report: Recommendations and Reports | 41.0 | 2 | 0 |
| The Journal of clinical and aesthetic dermatology | 41.0 | 2 | 0 |
| Alcohol research : current reviews | 41.0 | 2 | 0 |
| Vital & health statistics. Series 3, Analytical and epidemiological studies | 41.0 | 2 | 0 |
| Dermato-endocrinology | 41.0 | 2 | 0 |
| British Heart Journal | 41.0 | 2 | 0 |
| The western journal of emergency medicine | 41.0 | 2 | 0 |
| Psychiatry | 41.0 | 2 | 0 |
| Mycobiology | 41.0 | 2 | 0 |
| Vital and health statistics. Series 3, Analytical studies | 41.0 | 2 | 0 |
| Vital and health statistics. Ser. 4, Documents and committee reports | 41.0 | 2 | 0 |
| Vital and health statistics. Series 13, Data from the National Health Survey | 41.0 | 2 | 0 |
| Aging trends (Hyattsville, Md.) | 41.0 | 2 | 0 |
| NCHS data brief | 41.0 | 2 | 0 |
| MMWR supplements | 41.0 | 2 | 0 |
| U.S. News & World Report Best Colleges Ranking | 41.0 | 2 | 0 |
| National Center for Emerging and Zoonotic Infectious Diseases | 41.0 | 2 | 0 |
| Division of Parasitic Diseases and Malaria | 41.0 | 2 | 0 |
| Advanced Dermatology & Cosmetic Surgery | 41.0 | 2 | 0 |
| Mayo Clinic Health System | 41.0 | 2 | 0 |
| Chronic Disease Prevention and Health Promotion | 41.0 | 2 | 0 |
| UPMC Health System | 41.0 | 2 | 0 |
| Gold Skin Care Center | 41.0 | 2 | 0 |
| Laser and Skin Surgery Center of New York | 41.0 | 2 | 0 |
| Ohio State University Hospital | 41.0 | 2 | 0 |
| Syosset Hospital | 41.0 | 2 | 0 |
| Johns Hopkins Medicine | 41.0 | 2 | 0 |
| University of Utah Health Care | 41.0 | 2 | 0 |
| Topical Treatment of Basal Cell Carcinoma with the Immune Response Modifier Imiquimod | 40.0 | 0 | 4 |
| Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| Erratum: Mohs Surgery versus Standard Local Excision for Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Skin Cancer | 40.0 | 0 | 4 |
| skin cancer | 34.5 | 0 | 3 |
| Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group | 34.5 | 0 | 3 |
| Melanoma screening by means of complete skin exams for all patients in a dermatology practice reduces the thickness of primary melanomas at diagnosis | 34.5 | 0 | 3 |
| Skin Cancer Epidemiology, Detection, and Management | 34.5 | 0 | 3 |
| Association of CRR9 locus with elevated risk of squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Trends in Non-Melanoma Skin Cancer (Basal Cell Carcinoma and Squamous Cell Carcinoma) in Canada: A Descriptive Analysis of Available Data | 34.5 | 0 | 3 |
| Pattern of Nonmelanoma Skin Cancers in Sikkim, India: A 3-year Clinicopathological Review | 34.5 | 0 | 3 |
| Confocal microscopy patterns in nonmelanoma skin cancer and clinical applications | 34.5 | 0 | 3 |
| A 10-year review of outpatient skin biopsy results and skin cancer subtypes | 34.5 | 0 | 3 |
| Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know | 34.5 | 0 | 3 |
| Skin Cancer (Basal Cell Carcinoma, Squamous Cell Carcinoma, and Malignant Melanoma): New Cases, Treatment Practice, and Health Care Costs in New Brunswick, Canada, 2002–2010 | 34.5 | 0 | 3 |
| Defining recurrence of nonmelanoma skin cancer after Mohs micrographic surgery: Report of the American College of Mohs Surgery Registry and Outcomes Committee | 34.5 | 0 | 3 |
| Dermoscopy, Digital Dermoscopy and Other Diagnostic Tools in the Early Detection of Melanoma and Follow-up of High-risk Skin Cancer Patients. | 34.5 | 0 | 3 |
| Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Immunohistochemical analysis of TIMP-3 and MMP-9 in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 34.5 | 0 | 3 |
| Dermal changes in superficial basal cell carcinoma, melanoma in situ and actinic keratosis and their implications | 34.5 | 0 | 3 |
| An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis. | 34.5 | 0 | 3 |
| Multiple actinic keratosis, squamous cell carcinoma and basal cell carcinoma occurred after PUVA therapy in a Korean patient | 34.5 | 0 | 3 |
| Risk of subsequent basal cell carcinoma and squamous cell carcinoma of the skin among patients with prior skin cancer. Skin Cancer Prevention Study Group | 34.5 | 0 | 3 |
| Protein expression of MMP-2 and MT1-MMP in actinic keratosis, squamous cell carcinoma of the skin, and basal cell carcinoma. | 34.5 | 0 | 3 |
| The big three of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma | 34.5 | 0 | 3 |
| Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. | 34.5 | 0 | 3 |
| Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery | 34.5 | 0 | 3 |
| Multiple skin cancers in a single patient: Multiple pigmented Bowen's disease, giant basal cell carcinoma, squamous cell carcinoma | 34.5 | 0 | 3 |
| The expression of p53 and cox-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases | 34.5 | 0 | 3 |
| Basal cell carcinoma: shave biopsy versus punch biopsy technique in subtype diagnosis | 34.5 | 0 | 3 |
| Vitamin D Level and Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma Risk | 34.5 | 0 | 3 |
| Geographic variation and risk of skin cancer in US women. Differences between melanoma, squamous cell carcinoma, and basal cell carcinoma | 34.5 | 0 | 3 |
| Quantitative assessment of Langerhans cells in actinic keratosis, Bowen's disease, keratoacanthoma, squamous cell carcinoma and basal cell carcinoma | 34.5 | 0 | 3 |
| Non-melanoma skin cancer : Pathogenesis, prevalence and prevention | 34.5 | 0 | 3 |
| familial atypical multiple mole melanoma syndrome | 34.5 | 0 | 3 |
| Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults | 34.5 | 0 | 3 |
| Acitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer | 34.5 | 0 | 3 |
| Correlation Between Skin Carotenoid Levels and Previous History of Skin Cancer | 34.5 | 0 | 3 |
| Buddy Relationships in DermatoloGic Excisions for Skin Cancer | 34.5 | 0 | 3 |
| DNA repair synthesis in fibroblast strains from patients with actinic keratosis, squamous cell carcinoma, basal cell carcinoma, or malignant melanoma after treatment with ultraviolet light, N-acetoxy-2-acetyl-aminofluorene, methyl methanesulfonate, | 34.5 | 0 | 3 |
| The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma | 34.5 | 0 | 3 |
| Facing skin cancer surgery. Mohs surgery may be your best option for nonmelanoma skin cancers | 34.5 | 0 | 3 |
| Photodynamic Therapy in Treating Patients With Skin Cancer (1993-11-30) | 34.5 | 0 | 3 |
| Non-melanoma Skin Cancer - a Clinicopathological Study of Patients with Basal Cell Carcinoma and Squamous Cell Carcinoma | 34.5 | 0 | 3 |
| Appropriate use criteria for basal cell carcinoma Mohs surgery at a single center in the face of high-burden skin cancer: a retrospective cohort study | 34.5 | 0 | 3 |
| Recurrence of periocular basal cell carcinoma and squamous cell carcinoma after Mohs micrographic surgery: a retrospective cohort study | 34.5 | 0 | 3 |
| Early detection of melanoma: a consensus report from the Australian Skin and Skin Cancer Research Centre Melanoma Screening Summit | 34.5 | 0 | 3 |
| Nonmelanoma skin cancer - from actinic keratosis to cutaneous squamous cell carcinoma | 34.5 | 0 | 3 |
| Differences of Mohs micrographic surgery in basal cell carcinoma versus squamous cell carcinoma | 34.5 | 0 | 3 |
| Association between Blood Group and Nonmelanoma Skin Cancers (Basal Cell Carcinoma and Squamous Cell Carcinoma) | 34.5 | 0 | 3 |
| Photographic Rhinometry Following Derm/Mohs Surgery for Skin Cancers | 34.5 | 0 | 3 |
| Early detection of skin cancer using AI: Deciphering dermatology images for melanoma detection | 34.5 | 0 | 3 |
| Q135335149 | 34.5 | 0 | 3 |
| basal-cell carcinoma of the skin | 27.3 | 0 | 2 |
| Mohs surgery | 27.3 | 0 | 2 |
| Category:Skin cancer | 27.3 | 0 | 2 |
| dysplastic nevus syndrome | 27.3 | 0 | 2 |
| cutaneous squamous-cell carcinoma | 27.3 | 0 | 2 |
| David J. Hunter | 27.3 | 0 | 2 |
| E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma | 27.3 | 0 | 2 |
| Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix | 27.3 | 0 | 2 |
| Review of photodynamic therapy in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical staining for desmogleins 1 and 2 in keratinocytic neoplasms with squamous phenotype: actinic keratosis, keratoacanthoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Novel treatment options for nonmelanoma skin cancer: focus on electronic brachytherapy | 27.3 | 0 | 2 |
| Targeted Therapy for Orbital and Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Point of care cutaneous imaging technology in melanoma screening and mole mapping | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face | 27.3 | 0 | 2 |
| Dermoscopic differentiation of a superficial basal cell carcinoma and squamous cell carcinoma in situ | 27.3 | 0 | 2 |
| Q28274622 | 27.3 | 0 | 2 |
| Ingenol Disoxate: A Novel 4-Isoxazolecarboxylate Ester of Ingenol with Improved Properties for Treatment of Actinic Keratosis and Other Non-Melanoma Skin Cancers | 27.3 | 0 | 2 |
| Genome-wide association study identifies novel alleles associated with risk of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma vs basaloid squamous cell carcinoma of the skin: an immunohistochemical reappraisal. | 27.3 | 0 | 2 |
| Total body photography for skin cancer screening | 27.3 | 0 | 2 |
| XRCC3 C18067T Polymorphism Contributes a Decreased Risk to Both Basal Cell Carcinoma and Squamous Cell Carcinoma: Evidence from a Meta-Analysis | 27.3 | 0 | 2 |
| Application of Mohs micrographic surgery appropriate-use criteria to skin cancers at a university health system | 27.3 | 0 | 2 |
| Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. | 27.3 | 0 | 2 |
| Nasal cavity squamous cell carcinoma presenting as a nasal sidewall nodule: treatment with Mohs surgery, partial rhinectomy, and adjuvant radiotherapy | 27.3 | 0 | 2 |
| A novel optical imaging method for the early detection, quantitative grading, and mapping of cancerous and precancerous lesions of cervix | 27.3 | 0 | 2 |
| Mohs micrographic surgery of the nail unit and squamous cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. | 27.3 | 0 | 2 |
| Diagnostic and neural analysis of skin cancer (DANAOS). A multicentre study for collection and computer-aided analysis of data from pigmented skin lesions using digital dermoscopy. | 27.3 | 0 | 2 |
| The risk of non-melanoma skin cancer in HIV-infected patients: new data and meta-analysis | 27.3 | 0 | 2 |
| Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study. | 27.3 | 0 | 2 |
| High frequency of human papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania | 27.3 | 0 | 2 |
| Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ With a High-Energy Pulsed Carbon Dioxide Laser | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the lip treated with Mohs micrographic surgery: Outcome at 5 years | 27.3 | 0 | 2 |
| Guidelines for the management of squamous cell carcinoma in organ transplant recipients | 27.3 | 0 | 2 |
| Use of ex vivo confocal scanning laser microscopy during Mohs surgery for nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Repeated occurrence of basal cell carcinoma of the skin and multifailure survival analysis: follow-up data from the Nambour Skin Cancer Prevention Trial | 27.3 | 0 | 2 |
| Actinic keratoses, basal cell carcinoma, and squamous cell carcinoma: uncommon treatments | 27.3 | 0 | 2 |
| Photodynamic therapy for 50 patients with skin cancers or precancerous lesions | 27.3 | 0 | 2 |
| Heat shock protein 105 is overexpressed in squamous cell carcinoma and extramammary Paget disease but not in basal cell carcinoma | 27.3 | 0 | 2 |
| The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review | 27.3 | 0 | 2 |
| Current recommendations in the treatment of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| The actinic keratosis virome: can we prevent squamous cell carcinoma with a vaccine? | 27.3 | 0 | 2 |
| Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data | 27.3 | 0 | 2 |
| Proteomic diagnosis models from serum for early detection of oral squamous cell carcinoma | 27.3 | 0 | 2 |
| Should variation of serum lipid levels be considered a risk factor for the development of basal cell carcinoma? | 27.3 | 0 | 2 |
| Melanoma risk factors and atypical moles. | 27.3 | 0 | 2 |
| Expression of Cold-Inducible RNA-Binding Protein in Normal Skin, Actinic Keratosis and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A case of cutaneous squamous cell carcinoma arising in an actinic keratosis on the face in a centenarian woman successfully treated with surgery | 27.3 | 0 | 2 |
| Combined Detection of Plasma ZIC1, HOXD10 and RUNX3 Methylation is a Promising Strategy for Early Detection of Gastric Cancer and Precancerous Lesions | 27.3 | 0 | 2 |
| Early Detection of Superficial Squamous Cell Carcinoma in the Head and Neck Region and Esophagus by Narrow Band Imaging: A Multicenter Randomized Controlled Trial | 27.3 | 0 | 2 |
| Histopathology of incipient intraepidermal squamous cell carcinoma ("actinic keratosis"). | 27.3 | 0 | 2 |
| Early detection of esophageal squamous cell carcinoma and its effects on therapy: an overview | 27.3 | 0 | 2 |
| Squamous cell carcinoma, not basal cell carcinoma, is the most common cancer in humans | 27.3 | 0 | 2 |
| Early detection and treatment of skin cancer | 27.3 | 0 | 2 |
| Comparison of ex vivo optical coherence tomography with conventional frozen-section histology for visualizing basal cell carcinoma during Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Actinic keratosis is squamous cell carcinoma. | 27.3 | 0 | 2 |
| Systemic glucocorticoid use and early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| Citrus consumption and risk of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Knowledge, understanding, and use of preventive strategies against nonmelanoma skin cancer in healthy and immunosuppressed individuals undergoing Mohs surgery | 27.3 | 0 | 2 |
| Prevention, early detection and team management of skin cancer in primary care: contribution to The health of the nation objectives | 27.3 | 0 | 2 |
| Actinic keratosis treatment as a key component of preventive strategies for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Confocal microscopy-guided laser ablation for superficial and early nodular Basal cell carcinoma: a promising surgical alternative for superficial skin cancers | 27.3 | 0 | 2 |
| Sins of the sun. Tools for skin cancer prevention and early detection | 27.3 | 0 | 2 |
| Atypical mole syndrome and dysplastic nevi: identification of populations at risk for developing melanoma - review article | 27.3 | 0 | 2 |
| Systematic intraoperative application of confocal endomicroscopy for early detection and resection of squamous cell carcinoma of the head and neck: a preliminary report | 27.3 | 0 | 2 |
| Management of Squamous Cell Carcinoma of the Oral Tongue and Floor of Mouth After Excisional Biopsy | 27.3 | 0 | 2 |
| Selective use of sequential digital dermoscopy imaging allows a cost reduction in the melanoma detection process: a belgian study of patients with a single or a small number of atypical nevi | 27.3 | 0 | 2 |
| Management of oral squamous cell carcinoma treated with inadequate excisional biopsy | 27.3 | 0 | 2 |
| Sequential occurrence of basal cell carcinoma in symmetrically identical positions of both lower eyelids: A rare finding of a common skin cancer | 27.3 | 0 | 2 |
| Mohs micrographic surgery for facial skin cancer | 27.3 | 0 | 2 |
| Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery | 27.3 | 0 | 2 |
| Initial presentation of acute myelogenous leukemia in the infiltrate underlying an actinic keratosis | 27.3 | 0 | 2 |
| Optical Coherence Tomography–Based Optimization of Mohs Micrographic Surgery of Basal Cell Carcinoma: A Pilot Study | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Clinical correlative study on early detection of oral cancer and precancerous lesions by modified oral brush biopsy and cytology followed by histopathology | 27.3 | 0 | 2 |
| HLA Antigen Profile Differences in Patients with SCC (Squamous Cell Carcinoma) In-Situ /Actinic Keratosis and Invasive SCC: Is There a Genetic Succeptibility for Invasive SCC Development? | 27.3 | 0 | 2 |
| Multiple sequential skin cancers. The risk of skin cancer in patients with previous skin cancer | 27.3 | 0 | 2 |
| Pagetoid variant of actinic keratosis with or without squamous cell carcinoma of sun-exposed skin: a lesion simulating extramammary Paget's disease | 27.3 | 0 | 2 |
| Genomic instability in human actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma | 27.3 | 0 | 2 |
| Knowledge, perceptions, and practices of chiropractic interns in the early detection of atypical moles | 27.3 | 0 | 2 |
| TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Optimization of multimodal spectral imaging for assessment of resection margins during Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Measuring telomere length for the early detection of precursor lesions of esophageal squamous cell carcinoma. | 27.3 | 0 | 2 |
| Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling | 27.3 | 0 | 2 |
| Risk assessment and early detection of skin cancers | 27.3 | 0 | 2 |
| Efficacy of photodynamic therapy in the short and medium term in the treatment of actinic keratosis, Basal cell carcinoma, acne vulgaris and photoaging: results from four clinical trials | 27.3 | 0 | 2 |
| NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva. | 27.3 | 0 | 2 |
| Relationship of treatment delay with surgical defect size from keratinocyte carcinoma (basal cell carcinoma and squamous cell carcinoma of the skin). | 27.3 | 0 | 2 |
| Test characteristics of high-resolution ultrasound in the preoperative assessment of margins of basal cell and squamous cell carcinoma in patients undergoing Mohs micrographic surgery | 27.3 | 0 | 2 |
| Skin cancer education and early detection at the beach: A randomized trial of dermatologist examination and biometric feedback | 27.3 | 0 | 2 |
| Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma-treatments for the commonest skin cancer | 27.3 | 0 | 2 |
| Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC | 27.3 | 0 | 2 |
| Surgical attitude in premalignant lesions and malignant tumors of the lower lip | 27.3 | 0 | 2 |
| Plantar basal cell carcinoma in a patient with xeroderma pigmentosum: importance of dermoscopy for early diagnosis of nonpigmented skin cancer | 27.3 | 0 | 2 |
| 1064 nm long‐pulsed Nd:YAG laser treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil | 27.3 | 0 | 2 |
| Fundamentals of skin cancer/melanoma screening campaigns | 27.3 | 0 | 2 |
| Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods | 27.3 | 0 | 2 |
| Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models | 27.3 | 0 | 2 |
| Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited | 27.3 | 0 | 2 |
| Health economic evaluation of non-melanoma skin cancer and actinic keratosis | 27.3 | 0 | 2 |
| Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management | 27.3 | 0 | 2 |
| Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects | 27.3 | 0 | 2 |
| Ambient temperature and risk of first primary basal cell carcinoma: a nationwide United States cohort study | 27.3 | 0 | 2 |
| Photodynamic therapy followed by Mohs micrographic surgery compared to Mohs micrographic surgery alone for the treatment of basal cell carcinoma: Results of a pilot single-blinded randomised controlled trial | 27.3 | 0 | 2 |
| Early detection of skin cancer by family physicians: a pilot project | 27.3 | 0 | 2 |
| Novel Approaches to Imaging Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Common Dermatologic Procedures | 27.3 | 0 | 2 |
| The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes | 27.3 | 0 | 2 |
| Comparison of morphologic criteria for actinic keratosis and squamous cell carcinoma using in vivo multiphoton tomography | 27.3 | 0 | 2 |
| Incorporation of Electronic Brachytherapy for Skin Cancer into a Community Dermatology Practice | 27.3 | 0 | 2 |
| Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma | 27.3 | 0 | 2 |
| Total body skin examination for skin cancer screening among U.S. adults from 2000 to 2010 | 27.3 | 0 | 2 |
| Differential diagnosis of squamous cell carcinoma in situ using skin histopathological images | 27.3 | 0 | 2 |
| Screening and early detection of skin cancer | 27.3 | 0 | 2 |
| Giant epithelial malignancies (Basal cell carcinoma, squamous cell carcinoma): a series of 20 tumors from a single center | 27.3 | 0 | 2 |
| Melanoma screening: A plan for improving early detection | 27.3 | 0 | 2 |
| Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Breast carcinoma masquerading as basal cell carcinoma of the nipple | 27.3 | 0 | 2 |
| Factors associated with false-negative endoscopic biopsy results after neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). | 27.3 | 0 | 2 |
| Two Cases of Cutaneous Squamous Cell Carcinoma Arising in Immunosuppressed Patients with Chronic Human Papillomavirus Infection | 27.3 | 0 | 2 |
| Expression of E-, P- and N-Cadherin and Its Clinical Significance in Cervical Squamous Cell Carcinoma and Precancerous Lesions | 27.3 | 0 | 2 |
| Ablative Fractional Laser-Assisted Topical Fluorouracil for the Treatment of Superficial Basal Cell Carcinoma and Squamous Cell Carcinoma In Situ: A Follow-Up Study | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma arising in a naevus sebaceous of Jadassohn: case report and literature review | 27.3 | 0 | 2 |
| Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Presurgical mapping of basal cell carcinoma or squamous cell carcinoma by confocal laser endomicroscopy compared to traditional micrographic surgery: a single-centre prospective feasibility study | 27.3 | 0 | 2 |
| New histopathological classification of actinic keratosis (incipient intraepidermal squamous cell carcinoma). | 27.3 | 0 | 2 |
| The current role of in vivo reflectance confocal microscopy within the continuum of actinic keratosis and squamous cell carcinoma: a systematic review | 27.3 | 0 | 2 |
| The diagnostic concordance of actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis. | 27.3 | 0 | 2 |
| Monitoring Mitochondrial Complex-I Activity Using Novel PET Probe 18F-BCPP-EF Allows Early Detection of Radiotherapy Effect in Murine Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| The importance of superficial basal cell carcinoma in a retrospective study of 139 patients who underwent Mohs micrographic surgery in a Brazilian university hospital | 27.3 | 0 | 2 |
| Effectiveness of Mohs micrographic surgery for nonmelanoma skin cancer: a systematic review protocol. | 27.3 | 0 | 2 |
| Female estrogen-related factors and incidence of basal cell carcinoma in a nationwide US cohort | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the auricle and Mohs micrographic surgery | 27.3 | 0 | 2 |
| The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro | 27.3 | 0 | 2 |
| Basal cell carcinoma mistaken for actinic keratosis | 27.3 | 0 | 2 |
| Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer | 27.3 | 0 | 2 |
| Protein kinase Cepsilon and development of squamous cell carcinoma, the nonmelanoma human skin cancer | 27.3 | 0 | 2 |
| Multifocal squamous cell carcinoma arising in a Favre-Racouchot lesion – report of two cases and review of the literature | 27.3 | 0 | 2 |
| Basal cell carcinoma of the nail unit treated with Mohs micrographic surgery: superficial multicentric BCC with jagged borders--a histopathological hallmark for nail unit BCC. | 27.3 | 0 | 2 |
| Collision tumor of malignant skin cancers: a case of melanoma in basal cell carcinoma | 27.3 | 0 | 2 |
| A minimally invasive immunocytochemical approach to early detection of oral squamous cell carcinoma and dysplasia | 27.3 | 0 | 2 |
| Expression of matrix metalloproteinase-1, -2 and -3 in squamous cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness. | 27.3 | 0 | 2 |
| Evaluation of prospectively collected presenting signs/symptoms of biopsy-proven melanoma, basal cell carcinoma, squamous cell carcinoma, and seborrheic keratosis in an elderly male population | 27.3 | 0 | 2 |
| Topical therapy in the treatment of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Noninvasive Real-Time Automated Skin Lesion Analysis System for Melanoma Early Detection and Prevention | 27.3 | 0 | 2 |
| The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation | 27.3 | 0 | 2 |
| Tolerability of Ingenol Mebutate Gel, 0.05%, for Treating Patients with Actinic Keratosis on the Scalp in a Community Dermatology Practice | 27.3 | 0 | 2 |
| Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Crossroads between actinic keratosis and squamous cell carcinoma, and novel pharmacological issues | 27.3 | 0 | 2 |
| Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| Human polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer study | 27.3 | 0 | 2 |
| Distribution of Basal Cell Carcinoma and Squamous Cell Carcinoma by Facial Esthetic Unit | 27.3 | 0 | 2 |
| Reduced P53 staining in actinic keratosis is associated with squamous cell carcinoma: A preliminary study | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for skin cancer | 27.3 | 0 | 2 |
| The Self-Reported Knowledge, Attitude and the Practices Regarding the Early Detection of Oral Cancer and Precancerous Lesions among the Practising Dentists of Dakshina Kannada-A Pilot Study | 27.3 | 0 | 2 |
| Basal cell carcinoma of the skin with areas of squamous cell carcinoma: a basosquamous cell carcinoma? | 27.3 | 0 | 2 |
| Early Detection of Oral Squamous Cell Carcinoma ( O SCC ) – Role of Genetics: A Literature Review | 27.3 | 0 | 2 |
| Itch and Pain in Nonmelanoma Skin Cancer: Pain as an Important Feature of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| The Importance of a Full Clinical Examination: Assessment of Index Lesions Referred to a Skin Cancer Clinic Without a Total Body Skin Examination Would Miss One in Three Melanomas | 27.3 | 0 | 2 |
| ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction | 27.3 | 0 | 2 |
| Nonmelanoma skin cancers of the ear: correlation between subanatomic location and post-Mohs micrographic surgery defect size | 27.3 | 0 | 2 |
| Perineural invasion of cutaneous squamous cell carcinoma and basal cell carcinoma: raising awareness and optimizing management | 27.3 | 0 | 2 |
| Mycosis fungoides patient accompanied actinic keratosis, actinic keratosis with squamous cell carcinoma transformation, and porokeratosis after NBUVB therapy - 1st case report and review of the literature | 27.3 | 0 | 2 |
| Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Expression of heparanase in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels | 27.3 | 0 | 2 |
| Early detection of chromosome 9q22.32q31.1 microdeletion and the nevoid basal cell carcinoma syndrome | 27.3 | 0 | 2 |
| Patient Factors and Their Association with Nonmelanoma Skin Cancer Morbidity and the Performance of Self-skin Exams: A Cross-Sectional Study | 27.3 | 0 | 2 |
| Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri | 27.3 | 0 | 2 |
| Barriers to early detection and treatment of head and neck squamous cell carcinoma in African American men | 27.3 | 0 | 2 |
| Awareness of Skin Cancer, Prevention, and Early Detection among Turkish University Students | 27.3 | 0 | 2 |
| The Style Project: Feasibility of Collaborating With Salons for Prevention and Early Detection of Skin Cancer | 27.3 | 0 | 2 |
| Autoantibodies as Potential Biomarkers for the Early Detection of Esophageal Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Sun damage in ultraviolet photographs correlates with phenotypic melanoma risk factors in 12-year-old children. | 27.3 | 0 | 2 |
| Basal cell carcinoma invading the umbilical stalk excised with Mohs micrographic surgery: case report and review of umbilical anatomy | 27.3 | 0 | 2 |
| Incidence of atypical nevi in Olmsted County: an epidemiological study | 27.3 | 0 | 2 |
| Aldehyde dehydrogenase 1 expression in basal cell carcinoma, actinic keratosis and Bowen’s disease | 27.3 | 0 | 2 |
| Pigmented Basal Cell Carcinoma in Marjolin’s Ulcer | 27.3 | 0 | 2 |
| Treatment of cutaneous squamous cell carcinoma with perineural invasion using Mohs micrographic surgery: report of two cases and review of the literature | 27.3 | 0 | 2 |
| Mohs micrographic surgery for the management of nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Treatment options for squamous cell carcinoma of the dorsal hand including Mohs micrographic surgery | 27.3 | 0 | 2 |
| Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: A retrospective cohort study | 27.3 | 0 | 2 |
| The role of the nurse in skin cancer prevention, screening, and early detection. | 27.3 | 0 | 2 |
| Colonisation of Basal Cell Carcinoma and Actinic Keratosis by Malignant Melanoma In Situ in a Patient with Xeroderma Pigmentosum Variant | 27.3 | 0 | 2 |
| Rapid wound re-epithelialization and basal cell carcinoma clearance after Mohs micrographic surgery with postoperative photodynamic therapy | 27.3 | 0 | 2 |
| Mohs Micrographic Surgery for Eyelid and Periorbital Skin Cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in a nevus sebaceous of Jadassohn in a 9-year-old girl: treatment using Mohs micrographic surgery with literature review | 27.3 | 0 | 2 |
| Does basal cell carcinoma belong to the spectrum of sorafenib-induced epithelial skin cancers? | 27.3 | 0 | 2 |
| Perineural infiltration of cutaneous squamous cell carcinoma and basal cell carcinoma without clinical features | 27.3 | 0 | 2 |
| Dysplastic nevus (atypical nevus). | 27.3 | 0 | 2 |
| An overview of Mohs micrographic surgery for the treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma. | 27.3 | 0 | 2 |
| Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implications | 27.3 | 0 | 2 |
| A systematic review of advanced practice nurses’ skin cancer assessment barriers, skin lesion recognition skills, and skin cancer training activities | 27.3 | 0 | 2 |
| Skin cancer: a review with consideration of treatment options including Mohs micrographic surgery | 27.3 | 0 | 2 |
| Management of periocular basal cell carcinoma by Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Malignant melanoma within squamous cell carcinoma and basal cell carcinoma: is it a combined or collision tumor?--a case report and review of the literature | 27.3 | 0 | 2 |
| Therapeutic Options to Decrease Actinic Keratosis and Squamous Cell Carcinoma Incidence and Progression in Solid Organ Transplant Recipients: A Practical Approach | 27.3 | 0 | 2 |
| High discordance between punch biopsy and excision in establishing basal cell carcinoma subtype: analysis of 500 cases. | 27.3 | 0 | 2 |
| AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for M | 27.3 | 0 | 2 |
| Characteristics of Basal Cell Carcinoma of the Lip Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Characteristics of Squamous Cell Carcinoma In Situ of the Ear Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| The influence of the location of the lesion on the absolute risk of the development of skin cancer in a patient with actinic keratosis | 27.3 | 0 | 2 |
| Effect of GSTM1 polymorphism on risks of basal cell carcinoma and squamous cell carcinoma: a meta-analysis | 27.3 | 0 | 2 |
| Safety & efficacy of agents used for home mole removal and skin cancer treatment in the Internet age, and analysis of cases | 27.3 | 0 | 2 |
| Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control | 27.3 | 0 | 2 |
| Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system | 27.3 | 0 | 2 |
| Skin cancer and photoprotection in people of color: A review and recommendations for physicians and the public | 27.3 | 0 | 2 |
| Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice | 27.3 | 0 | 2 |
| Sinecatechins (Polyphenon E) ointment for treatment of external genital warts and possible future indications | 27.3 | 0 | 2 |
| Basosquamous carcinoma and metatypical basal cell carcinoma: a review of treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| The utility of re-excising mildly and moderately dysplastic nevi: A retrospective analysis | 27.3 | 0 | 2 |
| New Therapeutic Options for Actinic Keratosis and Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Study to determine whether intraoperative frozen section biopsy improves surgical treatment of non-melanoma skin cancer | 27.3 | 0 | 2 |
| Early detection of melanoma: reviewing the ABCDEs | 27.3 | 0 | 2 |
| Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome | 27.3 | 0 | 2 |
| On the horizon: Optical imaging for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth−Hitchcock experience | 27.3 | 0 | 2 |
| Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung | 27.3 | 0 | 2 |
| Screening the pathogenic genes and pathways related to DMBA (7,12-dimethylbenz[a]anthracene)-induced transformation of hamster oral mucosa from precancerous lesions to squamous cell carcinoma | 27.3 | 0 | 2 |
| Association Between Mohs Surgery Wait Times and Surgical Defect Size in Patients With Squamous Cell or Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Topical therapies for skin cancer and actinic keratosis | 27.3 | 0 | 2 |
| Actinic keratosis and squamous cell carcinoma: clinical and pathological features | 27.3 | 0 | 2 |
| Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens | 27.3 | 0 | 2 |
| Laboratory Errors Leading to Nonmelanoma Skin Cancer Recurrence After Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Mohs Surgery for Squamous Cell Carcinoma of the Nail Unit: 10 Years of Experience | 27.3 | 0 | 2 |
| Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma in-situ and Basal Cell Carcinoma Arising From Seborrheic Keratosis in the Same Patient | 27.3 | 0 | 2 |
| Utilization of Topographical Mohs Micrographic Surgery Maps for Rapid Review of Clinicopathologic Characteristics of Nonmelanoma Skin Cancers of the Ear. | 27.3 | 0 | 2 |
| Consensus for Nonmelanoma Skin Cancer Treatment, Part II: Squamous Cell Carcinoma, Including a Cost Analysis of Treatment Methods | 27.3 | 0 | 2 |
| CpG location and methylation level are crucial factors for the early detection of oral squamous cell carcinoma in brushing samples using bisulfite sequencing of a 13-gene panel. | 27.3 | 0 | 2 |
| Photodynamic Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Intralesional 5-fluorouracil (FU) as a treatment for nonmelanoma skin cancer (NMSC): A review | 27.3 | 0 | 2 |
| Skin cancer--early detection | 27.3 | 0 | 2 |
| Reconstruction of Large Facial Defects after Delayed Mohs Surgery for Skin Cancer | 27.3 | 0 | 2 |
| Mohs micrographic surgery for skin cancers of the neck | 27.3 | 0 | 2 |
| Is early detection of basal cell carcinoma worthwhile? Systematic review based on the WHO criteria for screening | 27.3 | 0 | 2 |
| Diagnostic accuracy of confocal microscopy imaging vs. punch biopsy for diagnosing and subtyping basal cell carcinoma | 27.3 | 0 | 2 |
| Familial skin cancer syndromes: Increased melanoma risk. | 27.3 | 0 | 2 |
| Familial skin cancer syndromes: Increased risk of nonmelanotic skin cancers and extracutaneous tumors | 27.3 | 0 | 2 |
| Mohs micrographic surgery for skin cancer | 27.3 | 0 | 2 |
| Diagnosis and Management of Hereditary Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Bensal HP for Second Intention Healing Following Mohs Micrographic Surgery or Shave Skin Biopsy: An Open-label Pilot Study | 27.3 | 0 | 2 |
| Outlier Practice Patterns in Mohs Micrographic Surgery: Defining the Problem and a Proposed Solution | 27.3 | 0 | 2 |
| Recurrence rates of periocular basal cell carcinoma following Mohs micrographic surgery: a retrospective study | 27.3 | 0 | 2 |
| Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years | 27.3 | 0 | 2 |
| CONSENSUS REPORT: Recognizing non-melanoma skin cancer, including actinic keratosis, as an occupational disease - A Call to Action. | 27.3 | 0 | 2 |
| Questionnaire-based evaluation of occupational and non-occupational solar radiation exposure in a sample of Italian patients treated for actinic keratosis and other non-melanoma skin cancers. | 27.3 | 0 | 2 |
| Updates on Precancerous Lesions of the Biliary Tract: Biliary Precancerous Lesion | 27.3 | 0 | 2 |
| Self-reported quality of life after skin cancer in young adults | 27.3 | 0 | 2 |
| Food intake and risk of squamous cell carcinoma of the skin in a community: the Nambour skin cancer cohort study | 27.3 | 0 | 2 |
| Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| Basal cell carcinoma in a patient with acquired immunodeficiency syndrome: treatment with Mohs micrographic surgery fixed-tissue technique | 27.3 | 0 | 2 |
| Second-intention healing of exposed facial-scalp bone after Mohs surgery for skin cancer: review of ninety-one cases. | 27.3 | 0 | 2 |
| Cutaneous melanin density of Caucasians measured by spectrophotometry and risk of malignant melanoma, basal cell carcinoma, and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Study of microvascular density and expression of vascular endothelial growth factor and its receptors in cancerous and precancerous lesions of the eyelids | 27.3 | 0 | 2 |
| Anatomical Distributions of Basal Cell Carcinoma and Squamous Cell Carcinoma in a Population-Based Study in Queensland, Australia. | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma: pathophysiology revisited | 27.3 | 0 | 2 |
| Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients | 27.3 | 0 | 2 |
| Survey of Patient Satisfaction With Ingenol Mebutate Gel Treatment for Actinic Keratosis From a Community Dermatology Practice | 27.3 | 0 | 2 |
| Actinic keratosis: a case of sun damage in the tropics | 27.3 | 0 | 2 |
| Incidence of skin cancers and precancerous lesions in Japanese--risk factors and prevention. | 27.3 | 0 | 2 |
| Early investigation by fluor-18-fluorodeoxyglucose positron emission tomography of a metastatic basal cell carcinoma presenting with spinal cord compression: A case report | 27.3 | 0 | 2 |
| Costs of Keratinocyte Carcinoma (Nonmelanoma Skin Cancer) and Actinic Keratosis Treatment in the Veterans Health Administration | 27.3 | 0 | 2 |
| Quantification of PpIX concentration in basal cell carcinoma and squamous cell carcinoma models using spatial frequency domain imaging | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma. Recognition and treatment | 27.3 | 0 | 2 |
| Molecular discrimination of cutaneous squamous cell carcinoma from actinic keratosis and normal skin | 27.3 | 0 | 2 |
| Superficial basal cell carcinoma on the face is a diagnostic challenge | 27.3 | 0 | 2 |
| Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography | 27.3 | 0 | 2 |
| Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors | 27.3 | 0 | 2 |
| Impact of digital dermoscopy analysis on the decision to follow up or to excise a pigmented skin lesion: a multicentre study. | 27.3 | 0 | 2 |
| Risks of different skin tumor combinations after a first melanoma, squamous cell carcinoma and basal cell carcinoma in Dutch population based cohorts: 1989 - 2009. | 27.3 | 0 | 2 |
| Mohs surgery for squamous cell carcinoma of the nail: report of 15 cases. Our experience and a long‐term follow‐up | 27.3 | 0 | 2 |
| Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic | 27.3 | 0 | 2 |
| Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| High magnification digital dermoscopy of basal cell carcinoma: a single-centre study on 400 cases. | 27.3 | 0 | 2 |
| Incidence and Trends of Basal Cell Carcinoma and Cutaneous Squamous Cell Carcinoma: A Population-Based Study in Olmsted County, Minnesota, 2000 to 2010. | 27.3 | 0 | 2 |
| Can video thermography improve differential diagnosis and therapy between basal cell carcinoma and actinic keratosis? | 27.3 | 0 | 2 |
| Skin cancers and precancerous lesions in Parkinson's disease patients. | 27.3 | 0 | 2 |
| A 13-Year Retrospective Study of Basal Cell Carcinoma in a Canadian Dermatology Practice: A Comparison Between Anatomical Location and Histopathologic Subtypes | 27.3 | 0 | 2 |
| Favourable results of Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Do centralised skin screening clinics increase participation in melanoma screening (Australia)? | 27.3 | 0 | 2 |
| Pain evaluation in patients affected by cutaneous squamous cell carcinoma and actinic keratosis: an observational study | 27.3 | 0 | 2 |
| Incidence ratio of basal cell carcinoma to squamous cell carcinoma equalizes with age. | 27.3 | 0 | 2 |
| The Skin Cancer Objective Structured Clinical Examination (SCOSCE): A multi-institutional collaboration to develop and validate a clinical skills assessment for melanoma | 27.3 | 0 | 2 |
| MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions | 27.3 | 0 | 2 |
| Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: a hospital-based survey | 27.3 | 0 | 2 |
| Retinoblastoma protein function and p16INK4a expression in actinic keratosis, squamous cell carcinoma in situ and invasive squamous cell carcinoma of the skin and links between p16INK4a expression and infiltrative behavior | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma | 27.3 | 0 | 2 |
| Relationship between arsenic‐containing drinking water and skin cancers in the arseniasis endemic areas in Taiwan | 27.3 | 0 | 2 |
| Actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| P16INK4aImmunostaining but Lack of Human Papilloma Virus Type 16 in Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: a Report from West Iran | 27.3 | 0 | 2 |
| Results of second‐stage screening for skin cancers in Oita Prefecture, Japan | 27.3 | 0 | 2 |
| Squamous cell carcinoma developing within lichen planus of the penis. Treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Surgical treatment of basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion | 27.3 | 0 | 2 |
| Mohs surgery of basal cell carcinoma--a critical review | 27.3 | 0 | 2 |
| Relationship of tumor thickness in punch biopsy and subsequent surgical specimens in stage I squamous cell carcinoma of the lower lip. | 27.3 | 0 | 2 |
| Bias in the assessment of family history of melanoma and its association with dysplastic nevi in a case-control study | 27.3 | 0 | 2 |
| Dysplastic nevi-dysplastic nevus syndromes: clinical features and genetic aspects | 27.3 | 0 | 2 |
| Subtype analysis and clinical significance of HPV infection in laryngeal squamous cell carcinoma and precancerous lesions | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the head and neck: management after excisional biopsy of a solitary metastatic neck node. | 27.3 | 0 | 2 |
| Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Risk of skin cancer in multiple myeloma patients: a retrospective cohort study | 27.3 | 0 | 2 |
| Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. | 27.3 | 0 | 2 |
| Primary cutaneous myxoid spindle cell squamous cell carcinoma: a rare skin cancer | 27.3 | 0 | 2 |
| Costs and Economics of Skin Cancer Management, Mohs Surgery, and Surgical Reconstruction | 27.3 | 0 | 2 |
| Skin cancer prevention and early detection intentions and behavior. | 27.3 | 0 | 2 |
| Skin cancer prevention: a link between primary prevention and early detection? | 27.3 | 0 | 2 |
| The development of non-melanocytic skin cancers in people with a history of skin cancer | 27.3 | 0 | 2 |
| How many nonmelanoma skin cancers require Mohs micrographic surgery? | 27.3 | 0 | 2 |
| Omental transplantation improves surgical outcome of large squamous cell carcinoma: A case report | 27.3 | 0 | 2 |
| Repair of directly and indirectly UV-induced DNA lesions and of DNA double-strand breaks in cells from skin cancer-prone patients with the disorders dysplastic nevus syndrome or basal cell nevus syndrome | 27.3 | 0 | 2 |
| Mohs micrographic surgery for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Molecular epidemiology of skin cancers: DNA repair and non-melanocytic skin cancer | 27.3 | 0 | 2 |
| User preferences for text message-delivered skin cancer prevention and early detection. | 27.3 | 0 | 2 |
| Squamous cell carcinoma. Case report of an unusually aggressive skin cancer | 27.3 | 0 | 2 |
| Mohs micrographic surgery for the treatment of difficult skin cancers | 27.3 | 0 | 2 |
| Redefining Dermatologists' Role in Skin Cancer Early Detection and Follow-up Care. | 27.3 | 0 | 2 |
| Prognostic factors for cutaneous squamous cell and basal cell carcinoma. Determinants of risk of recurrence, metastasis, and development of subsequent skin cancers | 27.3 | 0 | 2 |
| Clinical characteristics of malignant tumours originating in the external ear | 27.3 | 0 | 2 |
| Genetic association between TNF-α promoter polymorphism and susceptibility to squamous cell carcinoma, basal cell carcinoma, and melanoma: A meta-analysis | 27.3 | 0 | 2 |
| Mouse models for actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Can skin cancer prevention and early detection be improved via mobile phone text messaging? A randomised, attention control trial. | 27.3 | 0 | 2 |
| Comparison of electronic brachytherapy and Mohs micrographic surgery for the treatment of early-stage non-melanoma skin cancer: a matched pair cohort study | 27.3 | 0 | 2 |
| From sunlight to actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Delivering value in dermatology: Insights from skin cancer detection in routine clinical visits | 27.3 | 0 | 2 |
| Clinical Characteristics of Non-Melanoma Skin Cancers Recurring within 5 years after Mohs Micrographic Surgery: Single Institution Retrospective Chart Review | 27.3 | 0 | 2 |
| Childhood actinic keratosis in an albino transforming into squamous cell carcinoma. | 27.3 | 0 | 2 |
| Automatic detection of basal cell carcinoma using telangiectasia analysis in dermoscopy skin lesion images | 27.3 | 0 | 2 |
| Maximizing early detection of esophageal squamous cell carcinoma via SILAC-proteomics | 27.3 | 0 | 2 |
| Use of Ber-EP4 and Epithelial Specific Antigen to Differentiate Clinical Simulators of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| The need for early detection of neck nodal metastasis in squamous cell carcinoma of oral cavity | 27.3 | 0 | 2 |
| Detection of Human Papillomavirus in Nonmelanoma Skin Cancer Lesions and Healthy Perilesional Skin in Kidney Transplant Recipients and Immunocompetent Patients | 27.3 | 0 | 2 |
| Penile squamous cell carcinoma: a review of the literature and case report treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Correction: E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice | 27.3 | 0 | 2 |
| Early detection of melanoma skin cancer | 27.3 | 0 | 2 |
| Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Does the Dual Use of Toluidine Blue and Hematoxylin and Eosin Staining Improve Basal Cell Carcinoma Detection by Mohs Surgery Trainees? | 27.3 | 0 | 2 |
| Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grunwald-Giemsa stained cutaneous tissue smear | 27.3 | 0 | 2 |
| Chemosurgical report: basal cell carcinoma involving the external auditory canal--treatment with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma | 27.3 | 0 | 2 |
| Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma | 27.3 | 0 | 2 |
| Excision vs Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma. | 27.3 | 0 | 2 |
| Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib | 27.3 | 0 | 2 |
| Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Shave biopsy without local anaesthetic to diagnose basal cell carcinoma and other skin tumours prior to definitive treatment: analysis of 109 lesions | 27.3 | 0 | 2 |
| Skin cancer: Basal cell carcinoma--pay your money, take your choice | 27.3 | 0 | 2 |
| Head and neck skin cancer: dentists' responsibility in early detection | 27.3 | 0 | 2 |
| Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| Inserting ex vivo fluorescence confocal microscopy perioperatively in Mohs micrographic surgery expedites bedside assessment of excision margins in recurrent basal cell carcinoma | 27.3 | 0 | 2 |
| Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Comparison of the microvasculature of basal cell carcinoma and actinic keratosis using intravital microscopy and immunohistochemistry | 27.3 | 0 | 2 |
| Basal cell carcinoma, oculo-cutaneous albinism and actinic keratosis in a native Indian. | 27.3 | 0 | 2 |
| Multiple Sequential Skin Cancers: The Risk of Skin Cancer in Patients With Previous Skin Cancer | 27.3 | 0 | 2 |
| Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure | 27.3 | 0 | 2 |
| The efficacy of curettage in delineating margins of basal cell carcinoma before Mohs micrographic surgery | 27.3 | 0 | 2 |
| Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma | 27.3 | 0 | 2 |
| BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia. | 27.3 | 0 | 2 |
| The expression of c-erbB-1 and c-erbB-2 oncogenes in basal cell carcinoma and squamous cell carcinoma of skin | 27.3 | 0 | 2 |
| Re: Modulation of basal and squamous cell carcinoma by endogenous estrogen in mouse models of skin cancer | 27.3 | 0 | 2 |
| In vivo thickness measurement of basal cell carcinoma and actinic keratosis with optical coherence tomography and 20-MHz ultrasound | 27.3 | 0 | 2 |
| Histophotometric investigation of the nuclear DNA-content in normal epidermis, seborrheic keratosis, keratosis senilis, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| SNodular basal cell carcinoma appearing as morpheaform during Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Ultrastructural localization of gap junction protein connexin 43 in normal human skin, basal cell carcinoma, and squamous cell carcinoma | 27.3 | 0 | 2 |
| Nonmelanoma Skin Cancer: Disease-Specific Quality-of-Life Concerns and Distress | 27.3 | 0 | 2 |
| Atypical Adnexal Tumors Adjacent to Basal Cell Carcinoma: A Difficult Problem in Patients with Brooke-Spiegler Syndrome Undergoing Mohs Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients | 27.3 | 0 | 2 |
| Standard surgical excision and reconstruction of giant basal cell carcinoma of the face: may be an alternative to the Mohs micrographic surgery | 27.3 | 0 | 2 |
| Skin Cancer Education for Massage Therapists: A Novel Approach to the Early Detection of Suspicious Lesions | 27.3 | 0 | 2 |
| Efficacy of Fluorescence Diagnosis-guided Mohs Micrographic Surgery for Pigmented vs Non-pigmented Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Overlying a Cardiac Pacemaker Successfully Treated Using Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma of the ala nasi arising in a port wine stain treated using mohs micrographic surgery and local flap reconstruction | 27.3 | 0 | 2 |
| Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation | 27.3 | 0 | 2 |
| Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Marjolin's ulcer: immunohistochemical study of 17 cases and comparison with common squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| The basal lamina in basal cell carcinoma, bowen’s disease, squamous cell carcinoma and keratoacanthoma: an immunoperoxidase study using an antibody to type IV Collagen | 27.3 | 0 | 2 |
| P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma | 27.3 | 0 | 2 |
| Cystic basal cell carcinoma or hidrocytoma? The use of an excisional biopsy in a histopathologically challenging case | 27.3 | 0 | 2 |
| Cutaneous vitamin A levels in seborrheic keratosis, actinic keratosis, and basal cell carcinoma | 27.3 | 0 | 2 |
| Measurements of the anatomical distribution of erythemal ultraviolet: a study comparing exposure distribution to the site incidence of solar keratoses, basal cell carcinoma and squamous cell carcinoma. | 27.3 | 0 | 2 |
| The density of epidermal p53 clones is higher adjacent to squamous cell carcinoma in comparison with basal cell carcinoma. | 27.3 | 0 | 2 |
| Squamous cell carcinoma: Could it be the most common skin cancer? | 27.3 | 0 | 2 |
| Multidisciplinary management of advanced basal cell carcinoma: report of four cases | 27.3 | 0 | 2 |
| A comparison of risk factors for malignant melanoma, squamous cell carcinoma and basal cell carcinoma in the UK. | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma assisted by dermoscopy: report of two cases | 27.3 | 0 | 2 |
| Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| The use of Mohs micrographic surgery for determination of residual tumor in incompletely excised basal cell carcinoma | 27.3 | 0 | 2 |
| Is curettage really necessary for basal cell carcinoma before Mohs micrographic surgery? | 27.3 | 0 | 2 |
| See-and-treat surgery for facial skin cancer | 27.3 | 0 | 2 |
| Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. | 27.3 | 0 | 2 |
| Altered distribution of 1-2B7B antigen in basal cell carcinoma, squamous cell carcinoma and Bowen's disease | 27.3 | 0 | 2 |
| Development of squamous cell carcinoma into basal cell carcinoma under treatment with Vismodegib | 27.3 | 0 | 2 |
| Treatment of aggressive basal cell carcinoma with intralesional interferon: Evaluation of efficacy by Mohs surgery | 27.3 | 0 | 2 |
| Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Nasal Valve Dysfunction after Mohs Surgery for Skin Cancer of the Nose | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Treated with Mohs Surgery: A Comparison of 54 Younger Patients with 1050 Older Patients | 27.3 | 0 | 2 |
| Cowden's disease. Association with squamous cell carcinoma of the tongue and perianal basal cell carcinoma | 27.3 | 0 | 2 |
| Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system | 27.3 | 0 | 2 |
| Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer | 27.3 | 0 | 2 |
| Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery | 27.3 | 0 | 2 |
| Risk of subsequent non-melanoma skin cancer in a cohort of patients with primary basal cell carcinoma | 27.3 | 0 | 2 |
| Commentary on the 'Reliability of skin biopsy in determining accurate tumor margins: a retrospective study following Mohs micrographic surgery'. | 27.3 | 0 | 2 |
| Mohs micrographic surgery for Basal cell carcinoma of the face | 27.3 | 0 | 2 |
| High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia | 27.3 | 0 | 2 |
| Photodynamic treatment of basal cell carcinoma and squamous cell carcinoma with hypericin | 27.3 | 0 | 2 |
| Awareness of, knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians | 27.3 | 0 | 2 |
| Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. | 27.3 | 0 | 2 |
| Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Georgia's most common skin cancer: basal cell carcinoma | 27.3 | 0 | 2 |
| Mutation spectra of epidermal p53 clones adjacent to basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Unique basaloid findings during Mohs surgery for basal cell carcinoma: a dermatopathology challenge | 27.3 | 0 | 2 |
| Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Incidence and risk factors for skin cancer following lung transplantation | 27.3 | 0 | 2 |
| Basal cell carcinoma. A case of longstanding neglect and a case of early detection. | 27.3 | 0 | 2 |
| Multiple subclinical syringomatous proliferations encountered during Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| It's time for “keratinocyte carcinoma” to replace the term “nonmelanoma skin cancer” | 27.3 | 0 | 2 |
| Skin cancer evaluation in transplant patients: a physician opinion survey with recommendations | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the maxillary sinus associated with nevoid basal cell carcinoma syndrome: report of a case with 21-year evaluation | 27.3 | 0 | 2 |
| Timing of subsequent new tumors in patients who present with basal cell carcinoma or cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| 5% imiquimod cream and reflectance-mode confocal microscopy as adjunct modalities to Mohs micrographic surgery for treatment of basal cell carcinoma | 27.3 | 0 | 2 |
| Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin | 27.3 | 0 | 2 |
| Nonpersistence of Basal Cell Carcinoma After Diagnostic Shave Biopsy: Reconstruction When Specimen Is Negative During Surgery | 27.3 | 0 | 2 |
| Vismodegib as a neoadjuvant treatment to Mohs surgery for aggressive basal cell carcinoma | 27.3 | 0 | 2 |
| Interferon therapy for basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Awareness, knowledge and attitudes to non-melanoma skin cancer and actinic keratosis among the general public | 27.3 | 0 | 2 |
| Family History of Skin Cancer Is Associated With Increased Risk of Cutaneous Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Preoperative Ultrasound and Photoacoustic Imaging of Nonmelanoma Skin Cancers | 27.3 | 0 | 2 |
| Lipid profile in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Early detection of skin cancer (EDISCIM) through the use of non-invasive confocal imaging. | 27.3 | 0 | 2 |
| Standard excision and reconstruction as an alternative to MMS for giant basal cell carcinoma? | 27.3 | 0 | 2 |
| Subtyping Basal Cell Carcinoma by Clinical Diagnosis Versus Punch Biopsy | 27.3 | 0 | 2 |
| A massive neglected giant basal cell carcinoma in a schizophrenic patient treated successfully with vismodegib | 27.3 | 0 | 2 |
| Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients. | 27.3 | 0 | 2 |
| An educational device for Mohs micrographic surgery. A three-dimensional model of basal cell carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Immunohistochemical study of the inflammatory infiltrate associated with feline cutaneous squamous cell carcinomas and precancerous lesions (actinic keratosis). | 27.3 | 0 | 2 |
| Mohs micrographic surgery for nonmelanoma skin cancer | 27.3 | 0 | 2 |
| BURNS and ERUPTS: novel mnemonics for detection of squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Prevalence of underdiagnosed aggressive non-melanoma skin cancers treated with Mohs micrographic surgery: analysis of 513 cases | 27.3 | 0 | 2 |
| Secondary Intention Healing following Mohs Micrographic Surgery for Basal Cell Carcinoma of the Nipple and Areola* | 27.3 | 0 | 2 |
| Basaloid squamous cell carcinoma with 'monster' cells: a mimic of pleomorphic basal cell carcinoma | 27.3 | 0 | 2 |
| Commentary on Laboratory Errors Leading to Nonmelanoma Skin Cancer Recurrence Following Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Subsequent skin cancer in patients with early-onset basal cell carcinoma | 27.3 | 0 | 2 |
| Plasma antioxidant defense in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Cutaneous Squamous Cell Carcinomas of the Lower Extremities Show Distinct Clinical and Pathologic Features | 27.3 | 0 | 2 |
| microRNA profiling for early detection of nonmelanoma skin cancer | 27.3 | 0 | 2 |
| Trends in basal cell carcinoma, squamous cell carcinoma, and melanoma of the skin from 1973 through 1987. | 27.3 | 0 | 2 |
| Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy | 27.3 | 0 | 2 |
| New primary basal cell carcinomas arising in skin flaps following Mohs micrographic surgery for primary and recurrent basal cell carcinoma | 27.3 | 0 | 2 |
| Risk of skin cancer development in 672 patients affected by actinic keratosis | 27.3 | 0 | 2 |
| Correlation between histologic findings on punch biopsy specimens and subsequent excision specimens in recurrent basal cell carcinoma | 27.3 | 0 | 2 |
| Mapping out skin cancer: Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma within the clinical picture of a chronic venous insufficiency in the third stage | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. | 27.3 | 0 | 2 |
| Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. | 27.3 | 0 | 2 |
| Peritumoral fibrosis in basal cell and squamous cell carcinoma mimicking perineural invasion: potential pitfall in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Early detection and non-invasive diagnosis of basal cell carcinoma using a dermatoscope | 27.3 | 0 | 2 |
| Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen | 27.3 | 0 | 2 |
| Restylane persistent for 23 months found during Mohs micrographic surgery: a source of confusion with hyaluronic acid surrounding basal cell carcinoma | 27.3 | 0 | 2 |
| Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis | 27.3 | 0 | 2 |
| Mohs micrographic surgery for basal cell carcinoma: evaluation of the indication criteria and predictive factors for extensive subclinical spread | 27.3 | 0 | 2 |
| Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Cyclin A and beta-catenin expression in actinic keratosis, Bowen's disease and invasive squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease | 27.3 | 0 | 2 |
| Reliability of Self-Reported Information on Skin Cancer Among Elderly Patients with Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Limitations of Ber‐EP4 for distinction of Bowen disease from basal cell carcinoma | 27.3 | 0 | 2 |
| Can basal cell carcinoma lateral border be determined by fluorescence diagnosis?: Verification by Mohs micrographic surgery | 27.3 | 0 | 2 |
| Ber-EP4-positive phenotype differentiates actinic keratosis from superficial basal cell carcinoma | 27.3 | 0 | 2 |
| Porphyrin formation in actinic keratosis and basal cell carcinoma after topical application of methyl 5-aminolevulinate | 27.3 | 0 | 2 |
| Clinical outcomes from skin screening clinics within a community-based melanoma screening program | 27.3 | 0 | 2 |
| Is a punch biopsy reliable in subtyping basal cell carcinoma? A systematic review | 27.3 | 0 | 2 |
| 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome | 27.3 | 0 | 2 |
| Penile basal cell carcinoma: two cases treated with Mohs micrographic surgery and remarks on pathogenesis | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. I. Basal cell carcinoma | 27.3 | 0 | 2 |
| A Unique Basaloid Proliferation Encountered During Mohs Surgery: Potential Pitfall for Overdiagnosis of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Bispectral fluorescence imaging of aggressive basal cell carcinoma combined with histopathological mapping: a preliminary study indicating a possible adjunct to Mohs micrographic surgery | 27.3 | 0 | 2 |
| 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma | 27.3 | 0 | 2 |
| Pre-treatment Evaluation of Basal Cell Carcinoma for Photodynamic Therapy: Comparative Measurement of Tumour Thickness in Punch Biopsy and Excision Specimens | 27.3 | 0 | 2 |
| Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face | 27.3 | 0 | 2 |
| Comparison of EMA,CEA, CD10 and Bcl-2 Biomarkers by Immunohistochemistry in Squamous Cell Carcinoma and Basal Cell Carcinoma of the Skin | 27.3 | 0 | 2 |
| Early detection of skin cancer via terahertz spectral profiling and 3D imaging | 27.3 | 0 | 2 |
| Expression of Podoplanin in Non-melanoma Skin Cancers and Actinic Keratosis | 27.3 | 0 | 2 |
| Facial skin myiasis associated with advanced skin cancer: failure of early detection | 27.3 | 0 | 2 |
| Direct Cost-Analysis of Mohs Micrographic Surgery and Traditional Excision for Basal Cell Carcinoma at Initial Margin Clearance. | 27.3 | 0 | 2 |
| Diagnostic Accuracy in Subtyping Basal Cell Carcinoma by Clinical Diagnosis Compared with Punch Biopsy | 27.3 | 0 | 2 |
| Mohs micrographic surgery: reconstruction and nursing considerations for nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma | 27.3 | 0 | 2 |
| Skin cancer. Melanoma and other specific nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Expression of Minichromosome Maintenance Proteins in Actinic Keratosis and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| A new algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma based on in vivo analysis of optical properties by high-definition optical coherence tomography. | 27.3 | 0 | 2 |
| Basal cell carcinoma screening drives a comprehensive approach to skin cancer | 27.3 | 0 | 2 |
| Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| A Limited Immunohistochemical Panel to Distinguish Basal Cell Carcinoma of Cutaneous Origin From Basaloid Squamous Cell Carcinoma of the Head and Neck | 27.3 | 0 | 2 |
| Effects of ultraviolet radiation exposure on FOXP3+ infiltration in cutaneous squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Diagnostic accuracy of optical coherence tomography in actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Economic impact of preoperative curettage before Mohs micrographic surgery for basal cell carcinoma | 27.3 | 0 | 2 |
| Diagnosis of aggressive subtypes of eyelid basal cell carcinoma by 2-mm punch biopsy: prospective and comparative study | 27.3 | 0 | 2 |
| Follicular proliferation or basal cell carcinoma? The first prospective U.K. study of this histological challenge during Mohs surgery | 27.3 | 0 | 2 |
| p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis | 27.3 | 0 | 2 |
| Mohs micrographic surgery for periorbital skin cancer | 27.3 | 0 | 2 |
| Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery | 27.3 | 0 | 2 |
| Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology | 27.3 | 0 | 2 |
| The nevoid basal cell carcinoma syndrome--Gorlin's syndrome. Multiple jaw cysts and skin cancer | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma: Not a Case-Control Study | 27.3 | 0 | 2 |
| Study on the Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma-Reply | 27.3 | 0 | 2 |
| Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study | 27.3 | 0 | 2 |
| Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Epidemiology of basal cell carcinoma and squamous cell carcinoma of the pinna | 27.3 | 0 | 2 |
| Difference between pigmented and nonpigmented basal cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Basal cell carcinoma growth in patients waiting for Mohs surgery: a prospective study | 27.3 | 0 | 2 |
| Standard step sectioning of skin biopsy specimens diagnosed as superficial basal cell carcinoma frequently yields deeper and more aggressive subtypes | 27.3 | 0 | 2 |
| Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the Medicare population | 27.3 | 0 | 2 |
| Use of Mohs Micrographic Surgery for the Treatment of Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma | 27.3 | 0 | 2 |
| Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma. | 27.3 | 0 | 2 |
| Skin cancer and surgical margins for basal cell carcinoma | 27.3 | 0 | 2 |
| Basal cell carcinoma: surgical margin detection using digital dermoscopy | 27.3 | 0 | 2 |
| The Method of En Face Frozen Section in Clearing Periocular Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery | 27.3 | 0 | 2 |
| Agreement between histological subtype on punch biopsy and surgical excision in primary basal cell carcinoma | 27.3 | 0 | 2 |
| Photodynamic therapy effective for the treatment of actinic keratosis and basal cell carcinoma in bullous pemphigoid patients | 27.3 | 0 | 2 |
| Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Telomerase activity in Kaposi's sarcoma, squamous cell carcinoma, and basal cell carcinoma. | 27.3 | 0 | 2 |
| Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population | 27.3 | 0 | 2 |
| Sarcoidosis Discovered During Mohs Surgery for Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Punch biopsy: one more possible stage in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Phasor-FLIM as a Screening Tool for the Differential Diagnosis of Actinic Keratosis, Bowen's Disease, and Basal Cell Carcinoma. | 27.3 | 0 | 2 |
| Clinical Value of Paraffin Sections in Association with Mohs Micrographic Surgery for Nonmelanoma Skin Cancers | 27.3 | 0 | 2 |
| Cost Analysis of Mohs Micrographic Surgery in High-Risk Facial Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Diagnostic accuracy of punch biopsy in subtyping basal cell carcinoma. | 27.3 | 0 | 2 |
| Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib. | 27.3 | 0 | 2 |
| The Delphi panel in the economic evaluation of photodynamic therapy for actinic keratosis and basal cell carcinoma: poor results? | 27.3 | 0 | 2 |
| Nitric oxide and endothelin‐1,2 in actinic keratosis and basal cell carcinoma: changes in nitric oxide/endothelin ratio | 27.3 | 0 | 2 |
| Recurrent basal cell carcinoma and Mohs surgery. | 27.3 | 0 | 2 |
| Use of Mohs micrographic surgery to treat basal cell carcinoma arising in a nevus sebaceous in an African American patient | 27.3 | 0 | 2 |
| Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression | 27.3 | 0 | 2 |
| Hormonal and reproductive factors and incidence of basal cell carcinoma and squamous cell carcinoma in a large, prospective cohort. | 27.3 | 0 | 2 |
| Use of a Perimeter Technique with Mohs Micrographic Surgery in the Resection of a Giant Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery | 27.3 | 0 | 2 |
| Increased concentrations of 3,4-didehydroretinol and retinoic acid-binding protein (CRABPII) in human squamous cell carcinoma and keratoacanthoma but not in basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma | 27.3 | 0 | 2 |
| Correlation Between Incisional Biopsy Histological Subtype and a Mohs Surgery Specimen for Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Cutaneous Basal Cell Carcinoma with Dual Differentiation into Squamous Cell Carcinoma and Spindle Cell Squamous Cell Carcinoma: A Case Report with Immunohistochemical Studies | 27.3 | 0 | 2 |
| Mohs micrographic surgery for difficult skin cancers | 27.3 | 0 | 2 |
| Incidence of Residual Nonmelanoma Skin Cancer in Excisions After Shave Biopsy | 27.3 | 0 | 2 |
| The Ratio of Basal Cell Carcinoma to Squamous Cell Carcinoma in Houston, Texas | 27.3 | 0 | 2 |
| Cytological diagnosis of basal cell carcinoma and actinic keratosis, using Papanicolaou and May-Grünwald-Giemsa stained cutaneous tissue smear | 27.3 | 0 | 2 |
| Human cadaveric allograft for repair of nasal defects after extirpation of Basal cell carcinoma by Mohs micrographic surgery | 27.3 | 0 | 2 |
| The effect of solar UVB doses and vitamin D production, skin cancer action spectra, and smoking in explaining links between skin cancers and solid tumours | 27.3 | 0 | 2 |
| Solitary sebaceous nevus of Jadassohn complicated by squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Predictors of skin-related quality of life after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Topical tretinoin in actinic keratosis and basal cell carcinoma. | 27.3 | 0 | 2 |
| Longitudinal diminution of tumor size for basal cell carcinoma suggests shifting referral patterns for Mohs surgery | 27.3 | 0 | 2 |
| Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients | 27.3 | 0 | 2 |
| A pilot study comparing toluidine blue and hematoxylin and eosin staining of basal cell and squamous cell carcinoma during Mohs surgery | 27.3 | 0 | 2 |
| Expression of CD40 and Fas ligand in Bowen's disease, squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Methyl-ALA-induced fluorescence in photodynamic diagnosis of basal cell carcinoma prior to Mohs micrographic surgery. | 27.3 | 0 | 2 |
| Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update | 27.3 | 0 | 2 |
| Excision of a peristomal basal cell carcinoma using Mohs micrographic surgery | 27.3 | 0 | 2 |
| Mohs surgery in the treatment of skin cancer. | 27.3 | 0 | 2 |
| Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin | 27.3 | 0 | 2 |
| Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group | 27.3 | 0 | 2 |
| Expression of vascular endothelial growth factor in basal cell carcinoma and cutaneous squamous cell carcinoma of the head and neck | 27.3 | 0 | 2 |
| Ingenol mebutate: A novel topical drug for actinic keratosis | 27.3 | 0 | 2 |
| Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study | 27.3 | 0 | 2 |
| Fluorescence diagnosis in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| The value of mohs surgery for the treatment of nonmelanoma skin cancers | 27.3 | 0 | 2 |
| Expressions of receptor-interacting protein and caspase-8 in oral squamous cell carcinoma and oral precancerous lesions | 27.3 | 0 | 2 |
| Synthesis, biological evaluation and SAR of 3-benzoates of ingenol for treatment of actinic keratosis and non-melanoma skin cancer | 27.3 | 0 | 2 |
| Total body photography for melanoma surveillance | 27.3 | 0 | 2 |
| Reply to 'Digital dermoscopy analysis and internet-based program for discrimination of pigmented skin lesion dermoscopic images'. | 27.3 | 0 | 2 |
| Reflectance confocal microscopy: non-invasive distinction between actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| Skin cancer knowledge and preventive behaviors among patients with a recent history of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Effects on skills and practice from a web-based skin cancer course for primary care providers. | 27.3 | 0 | 2 |
| Dysplastic nevi. Occurrence in first- and second-degree relatives of patients with 'sporadic' dysplastic nevus syndrome | 27.3 | 0 | 2 |
| Skin cancer rates are rapidly increasing. Early detection should be promoted | 27.3 | 0 | 2 |
| Actinic keratosis: epidemiology and progression to squamous cell carcinoma | 27.3 | 0 | 2 |
| Office based dermatological surgery and Mohs surgery: A prospective audit of surgical procedures and complications in a procedural dermatology practice | 27.3 | 0 | 2 |
| Skin cancer and sun radiation: peruvian experience in the prevention and early detection of skin cancer and melanoma | 27.3 | 0 | 2 |
| Histopathologic characteristics of dysplastic nevi. Limited association of conventional histologic criteria with melanoma risk group | 27.3 | 0 | 2 |
| Squamous cell carcinoma of the eyelids. Review of 7 years of experience of the adult ophthalmology service of the Casablanca university medical center | 27.3 | 0 | 2 |
| Detection of human papillomavirus in cutaneous clear cell squamous cell carcinoma in situ: viral-associated oncogenesis may contribute to the development of this pathologic variant of skin cancer | 27.3 | 0 | 2 |
| Expression of promyelocytic leukaemia protein in Bowen's disease, skin squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| In actinic keratosis and basal cell carcinoma. The power of light heals without scars | 27.3 | 0 | 2 |
| US patients get faster access to botulinum toxin than for suspicious mole checks | 27.3 | 0 | 2 |
| Acantholytic squamous cell carcinoma is usually associated with hair follicles, not acantholytic actinic keratosis, and is not "high risk": Diagnosis, management, and clinical outcomes in a series of 115 cases | 27.3 | 0 | 2 |
| A randomized, double-blind comparison of the total dose of 1.0% lidocaine with 1:100,000 epinephrine versus 0.5% lidocaine with 1:200,000 epinephrine required for effective local anesthesia during Mohs micrographic surgery for skin cancers. | 27.3 | 0 | 2 |
| Increased osteopontin expression is associated with progression from vulvar precancerous lesions to vulvar squamous cell carcinoma | 27.3 | 0 | 2 |
| Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study | 27.3 | 0 | 2 |
| Efficacy of Photodynamic Diagnosis-Guided Mohs Micrographic Surgery in Primary Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Early detection of squamous cell carcinoma in carcinogen induced oral cancer rodent model by ratiometric activatable cell penetrating peptides | 27.3 | 0 | 2 |
| The Skin Cancer Quality of Life Impact Tool (SCQOLIT): a validated health-related quality of life questionnaire for non-metastatic skin cancers | 27.3 | 0 | 2 |
| UV-Induced Molecular Signaling Differences in Melanoma and Non-melanoma Skin Cancer | 27.3 | 0 | 2 |
| Solar keratosis: from precancerous lesion to pre-invasive squamous cell carcinoma--therapeutic approach with a bioinductive method | 27.3 | 0 | 2 |
| Topical chemotherapy for actinic keratosis and nonmelanoma skin cancer: current options and future perspectives | 27.3 | 0 | 2 |
| Donor-derived keratinocytes in actinic keratosis and squamous cell carcinoma in patients with kidney transplant | 27.3 | 0 | 2 |
| Medical Student Decision-Making: Standard Surgical Excision or Mohs Micrographic Surgery to Manage Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics. | 27.3 | 0 | 2 |
| Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery | 27.3 | 0 | 2 |
| Peroxiredoxin-2 and zinc-alpha-2-glycoprotein as potentially combined novel salivary biomarkers for early detection of oral squamous cell carcinoma using proteomic approaches. | 27.3 | 0 | 2 |
| Factors Influencing Squamous Cell Carcinoma In Situ Recurrence and Implications for Treatment Choice | 27.3 | 0 | 2 |
| How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer | 27.3 | 0 | 2 |
| Curricular factors associated with medical students' practice of the skin cancer examination: an educational enhancement initiative by the integrated skin exam consortium | 27.3 | 0 | 2 |
| Clinical usefulness of Mohs' chemosurgery for palliative purposes in patients with cutaneous squamous cell carcinoma with risk factors or without indication for surgery: Three case reports | 27.3 | 0 | 2 |
| Use of a novel 1-hour protocol for rapid frozen section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery | 27.3 | 0 | 2 |
| The Integrated Skin Exam film: An educational intervention to promote early detection of melanoma by medical students | 27.3 | 0 | 2 |
| Retrospective audit of patients referred for further treatment following Mohs surgery for non-melanoma skin cancer. | 27.3 | 0 | 2 |
| High-definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma. | 27.3 | 0 | 2 |
| Factors affecting choice of repair in Mohs micrographic surgery for non-melanoma skin cancer of the head. | 27.3 | 0 | 2 |
| What's up dermatology? A pilot survey of the use of WhatsApp in dermatology practice and case discussion among members of WhatsApp dermatology groups. | 27.3 | 0 | 2 |
| Digital dermoscopy analysis and internet-based program for discrimination of pigmented skin lesion dermoscopic images. | 27.3 | 0 | 2 |
| Education in Early Detection of Oral Squamous Cell Carcinoma: A Community Outreach Program | 27.3 | 0 | 2 |
| Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Coll | 27.3 | 0 | 2 |
| Features Causing Confusion between Basal Cell Carcinoma and Squamous Cell Carcinoma in Clinical Diagnosis | 27.3 | 0 | 2 |
| Incidence of Actinic Keratosis and Risk of Skin Cancer in Subjects with Actinic Keratosis: A Population-based Cohort Study | 27.3 | 0 | 2 |
| Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression | 27.3 | 0 | 2 |
| Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment | 27.3 | 0 | 2 |
| Skin Lesion Analysis towards Melanoma Detection Using Deep Learning Network | 27.3 | 0 | 2 |
| Approach to moderately dysplastic nevi with positive histologic margins | 27.3 | 0 | 2 |
| Role of salivary biomarkers in early detection of oral squamous cell carcinoma | 27.3 | 0 | 2 |
| Actinic keratosis area and severity index (AKASI) is associated with the incidence of squamous cell carcinoma | 27.3 | 0 | 2 |
| Re: "How Mohs Surgery Transformed Into a First-Line Treatment of Skin Cancer". | 27.3 | 0 | 2 |
| Evaluation of T lymphocyte subpopulations in Actinic Keratosis, In Situ and Invasive Squamous Cell Carcinoma of the Skin. | 27.3 | 0 | 2 |
| Complete treatment of basal cell carcinoma; cost effectiveness of Mohs micrographic surgery versus conventional excision | 27.3 | 0 | 2 |
| Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study | 27.3 | 0 | 2 |
| The perineural corona sign: Enhancing detection of perineural squamous cell carcinoma during Mohs micrographic surgery with toluidine blue stain | 27.3 | 0 | 2 |
| Family history of skin cancer is associated with early-onset basal cell carcinoma independent of MC1R genotype. | 27.3 | 0 | 2 |
| Application of in vivo stain of methylene blue as a diagnostic aid in the early detection and screening of oral squamous cell carcinoma and precancer lesions | 27.3 | 0 | 2 |
| Use of methylene blue as a diagnostic aid in early detection of oral cancer and precancerous lesions | 27.3 | 0 | 2 |
| Dermatoscopy of facial actinic keratosis, intraepidermal carcinoma, and invasive squamous cell carcinoma: a progression model | 27.3 | 0 | 2 |
| Actinic keratosis: a cross‐sectional study of disease characteristics and treatment patterns in Danish dermatology clinics | 27.3 | 0 | 2 |
| Skin lesion image segmentation using Delaunay Triangulation for melanoma detection | 27.3 | 0 | 2 |
| Expressions of oncogenes c-fos and c-myc in skin lesion of cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Burden of Malignancy After a Primary Skin Cancer: Recurrence, Multiple Skin Cancers and Second Primary Cancers | 27.3 | 0 | 2 |
| False-negative findings in skin cancer and melanoma screening. | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| General practitioners' workload after skin cancer/melanoma screening clinics in The Netherlands | 27.3 | 0 | 2 |
| Melanonychia following mohs surgery for recurrent squamous cell carcinoma in situ of the nail bed. | 27.3 | 0 | 2 |
| Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma | 27.3 | 0 | 2 |
| Physician Survey Regarding Patient Nonattendance at Follow-up Appointments at a University-Affiliated Medical Dermatology Clinic | 27.3 | 0 | 2 |
| The ratio of non-hyperkeratotic and hyperkeratotic actinic keratosis in a high-risk non-melanoma skin cancer cohort in Queensland | 27.3 | 0 | 2 |
| Factors associated with the prevalence of atypical nevus in a Mediterranean pigmented skin lesion clinic | 27.3 | 0 | 2 |
| The Accuracy of Measurements of Nonmelanoma Skin Cancer Sizes Referred to the Mohs Surgery Clinic | 27.3 | 0 | 2 |
| W-modification of Abbe flap after Mohs surgery of squamous cell carcinoma on the lower lip. | 27.3 | 0 | 2 |
| Three years of retrospective evaluation of skin biopsy results in childhood | 27.3 | 0 | 2 |
| A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions | 27.3 | 0 | 2 |
| Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes | 27.3 | 0 | 2 |
| Actinic keratosis. A premalignant skin lesion | 27.3 | 0 | 2 |
| A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013, Istanbul, Turkey) | 27.3 | 0 | 2 |
| Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| How good are skin cancer clinics at melanoma detection? Number needed to treat variability across a national clinic group in Australia | 27.3 | 0 | 2 |
| Expression and clinical implications of enhancer of Zeste homolog 2 and p53 protein in squamous cell carcinoma and precancerous lesions in the cervix | 27.3 | 0 | 2 |
| Oral squamous cell carcinoma: an analysis of 1,564 cases showing advances in early detection | 27.3 | 0 | 2 |
| Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression | 27.3 | 0 | 2 |
| Aggressive Squamous Cell Carcinoma Within A Burn Scar Complicated by M. Fortuitum Infection: Combination Treatment With Antibiotic Therapy, Mohs Surgery, Amnion-Chorion Graft, and Low-Intensity Pulsed Dye Laser | 27.3 | 0 | 2 |
| Expression of Mcm7 and Cdc6 in oral squamous cell carcinoma and precancerous lesions. | 27.3 | 0 | 2 |
| Immunohistochemical study of the specific features of expression of matrix metalloproteinases 1, 9 in the photoaged skin, the foci of actinic keratosis and basal cell carcinoma | 27.3 | 0 | 2 |
| Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China | 27.3 | 0 | 2 |
| Basic skin cancer triage for teaching melanoma detection | 27.3 | 0 | 2 |
| Alterations of the Human Skin N- and O-Glycome in Basal Cell Carcinoma and Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS. | 27.3 | 0 | 2 |
| Therapeutic potential of the anti‐diabetic agent metformin in targeting the skin cancer stem cell diaspora | 27.3 | 0 | 2 |
| Early detection of precancerous lesions in dysplasias of the lung by rapid DNA image cytometry. | 27.3 | 0 | 2 |
| Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis | 27.3 | 0 | 2 |
| Preferential allelic deletion of RBSP3, LIMD1 and CDC25A in head and neck squamous cell carcinoma: Implication in cancer screening and early detection | 27.3 | 0 | 2 |
| The depth of follicular extension in actinic keratosis correlates with the depth of invasion in squamous cell carcinoma: implication for clinical treatment | 27.3 | 0 | 2 |
| In vivo microvascular imaging of cutaneous actinic keratosis, Bowen's disease and squamous cell carcinoma using dynamic optical coherence tomography. | 27.3 | 0 | 2 |
| Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification | 27.3 | 0 | 2 |
| Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Melanoma risk: adolescent females' perspectives on skin protection pre/post-viewing a ultraviolet photoaged photograph of their own facial sun damage | 27.3 | 0 | 2 |
| Methyl-aminolevulinic acid photodynamic therapy for actinic keratoses: a useful treatment or a risk factor? A retrospective study | 27.3 | 0 | 2 |
| Expression of p300 and p300/CBP associated factor (PCAF) in actinic keratosis and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| The serine protease inhibitor of Kazal-type 9 (SPINK9) is expressed in lichen simplex chronicus, actinic keratosis and squamous cell carcinoma. | 27.3 | 0 | 2 |
| Focal adhesion kinase and Src expression in premalignant and malignant skin lesions | 27.3 | 0 | 2 |
| Early detection of skin cancer | 27.3 | 0 | 2 |
| The Use of Dermoscopy in Medical Photography for the Early Detection of Skin Cancer | 27.3 | 0 | 2 |
| Interdigital squamous cell carcinomain situsuccessfully treated with modified Mohs micrographic surgery and a split-thickness skin graft | 27.3 | 0 | 2 |
| Expression of G1/S‐cyclins and cyclin‐dependent kinase inhibitors in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| The expressions of cyclooxygenase-2 (Cox-2),VEGF in oral squamous cell carcinoma and precancerous lesions and their significances | 27.3 | 0 | 2 |
| Research on expression of telomerase hTR gene in oral precancerous lesion and squamous cell carcinoma | 27.3 | 0 | 2 |
| The alteration of MTS1 gene in precancerous lesions and squamous cell carcinoma of oral mucosa | 27.3 | 0 | 2 |
| BRAF and RKIP aberrations in actinic keratosis and non-melanoma skin cancers | 27.3 | 0 | 2 |
| Punch biopsy vs. shave biopsy: a comparison of margin status of clinically atypical pigmented lesions | 27.3 | 0 | 2 |
| Actinic keratosis, Bowen's disease, keratoacanthoma and squamous cell carcinoma of the skin | 27.3 | 0 | 2 |
| Mohs micrographic surgery for squamous cell carcinoma associated with epidermolysis bullosa | 27.3 | 0 | 2 |
| Investigation of Werner protein as an early DNA damage response in actinic keratosis, Bowen disease and squamous cell carcinoma | 27.3 | 0 | 2 |
| From actinic keratosis to squamous cell carcinoma: evidence of morphologic and biologic progression | 27.3 | 0 | 2 |
| Effectively Disclosing Skin Biopsy Results | 27.3 | 0 | 2 |
| [Mohs surgery for basal cell carcinoma]. | 27.3 | 0 | 2 |
| Lip Repair after Mohs Surgery for Squamous Cell Carcinoma by Bilateral Tissue Expanding Vermillion Myocutaneous Flap (Goldstein Technique Modified by Sawada). | 27.3 | 0 | 2 |
| Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma and Basal Cell Carcinoma--The Frontline for Pathophysiology. Diagnosis and Therapy | 27.3 | 0 | 2 |
| Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes | 27.3 | 0 | 2 |
| Expression of P27, Ki67 and P53 in squamous cell carcinoma, actinic keratosis and Bowen disease | 27.3 | 0 | 2 |
| A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Comparison of P53 Intensity, Frequency and Size in Normal Skin Periphery of Squamous Cell Carcinoma, Basal Cell Carcinoma And Melanocytic Nevus in Persian Skin Type | 27.3 | 0 | 2 |
| DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing | 27.3 | 0 | 2 |
| Dysregulation of epidermal growth factor receptor in actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| Clinical Perspective of 3D Total Body Photography for Early Detection and Screening of Melanoma. | 27.3 | 0 | 2 |
| Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma | 27.3 | 0 | 2 |
| Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma. | 27.3 | 0 | 2 |
| GENOTYPING OF HUMAN PAPPILOMAVIRUS IN CERVICAL PRECANCEROUS LESION AND SQUAMOUS CELL CARCINOMA AT DR. SOETOMO HOSPITAL, SURABAYA, INDONESIA. | 27.3 | 0 | 2 |
| Promoting sunscreen use and skin self-examination to improve early detection and prevent skin cancer: quasi-experimental trial of an adolescent psycho-educational intervention | 27.3 | 0 | 2 |
| Squamous Cell Carcinoma Manifested as a Cutaneous Horn: A Key to Early Detection | 27.3 | 0 | 2 |
| Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma and precancerous lesions | 27.3 | 0 | 2 |
| Advances in Skin Cancer Early Detection and Diagnosis | 27.3 | 0 | 2 |
| Who attends skin cancer clinics within a randomized melanoma screening program? | 27.3 | 0 | 2 |
| Attitudes and intentions in relation to skin checks for early signs of skin cancer | 27.3 | 0 | 2 |
| A Predictive Model for Primary Closure Lengths in Mohs Surgery Based on Skin Cancer Type, Dimensions, and Location | 27.3 | 0 | 2 |
| Characteristics of Nonmelanoma Skin Cancers of the Cutaneous Perioral and Vermilion Lip Treated by Mohs Micrographic Surgery | 27.3 | 0 | 2 |
| Case Report: Squamous Cell Carcinoma Referred for Mohs Surgery Found to be Cutaneous Leishmaniasis | 27.3 | 0 | 2 |
| Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma | 27.3 | 0 | 2 |
| Incidence of Basal Cell Carcinoma and Squamous Cell Carcinoma in Patients on Antiprogrammed Cell Death-1 Therapy for Metastatic Melanoma | 27.3 | 0 | 2 |
| Commentary on Patients' Body Image Improves After Mohs Micrographic Surgery for Nonmelanoma Head and Neck Skin Cancer | 27.3 | 0 | 2 |
| A Natural History of Actinic Keratosis and Cutaneous Squamous Cell Carcinoma Microbiomes | 27.3 | 0 | 2 |
| Squamous cell carcinoma tumor thrombus encountered during Mohs micrographic surgery | 27.3 | 0 | 2 |
| Faculty of 1000 evaluation for Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling | 27.3 | 0 | 2 |
| Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience | 27.3 | 0 | 2 |
| Immunological effects of photodynamic therapy in the treatment of actinic keratosis and squamous cell carcinoma | 27.3 | 0 | 2 |
| How to decrease morbidity and mortality of skin cancer: primary prevention of skin cancer/screening of skin cancer. Report of a workshop held under the auspices of the Society of Dermatological Prevention (ADP e.V.), Commission of Early Detection and | 27.3 | 0 | 2 |
| Redesigning Skin Cancer Early Detection and Care Using a New Mobile Health Application: Protocol of the SKIN Research Project, a Randomised Controlled Trial | 27.3 | 0 | 2 |
| Clinical Value of Combining F-FDG PET/CT and Routine Serum Tumor Markers in The Early Detection of Recurrence Among Follow-up Patients Treated for Cervical Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Arteriovenous malformation after punch biopsy clinically mimicking a basal cell carcinoma: Case report and review of literature | 27.3 | 0 | 2 |
| Faculty of 1000 evaluation for Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study | 27.3 | 0 | 2 |
| Total body skin examination for skin cancer screening in patients with focused symptoms | 27.3 | 0 | 2 |
| Expression of Gelatinases (MMP-2, MMP-9) and Gelatinase Activator (MMP-14) in Actinic Keratosis and in In Situ and Invasive Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia | 27.3 | 0 | 2 |
| Early detection of skin cancer as public health policy: Comparison of campaign and routine activity | 27.3 | 0 | 2 |
| Effectiveness of interventions to support the early detection of skin cancer through skin self-examination: a systematic review and meta-analysis | 27.3 | 0 | 2 |
| Reflectance confocal microscopy for diagnosing keratinocyte skin cancers in adults | 27.3 | 0 | 2 |
| Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults | 27.3 | 0 | 2 |
| Checking Wether the m-ALA Cream Could Mark Correctly the Borders of BCC's Tumors | 27.3 | 0 | 2 |
| Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer | 27.3 | 0 | 2 |
| Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project | 27.3 | 0 | 2 |
| Ex vivo fluorescence confocal microscopy in conjunction with Mohs micrographic surgery for cutaneous squamous cell carcinoma | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides | 27.3 | 0 | 2 |
| Eflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer | 27.3 | 0 | 2 |
| Mobile Teledermatology for Melanoma Detection. Assessment of Validity in the Framework of a Population-based Skin Cancer Awareness Campaign in Northern Italy | 27.3 | 0 | 2 |
| Diagnosing Melanoma, Squamous Cell Carcinoma and Basal Cell Carcinoma Using the Spectra-Scope | 27.3 | 0 | 2 |
| Vismodegib for Treatment of Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Melanoma Risk Assessment & Tailored Intervention | 27.3 | 0 | 2 |
| Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Methyl-5-Aminolevulinate Hydrochloride Cream in Determining Pain Threshold in Patients With Skin Cancer | 27.3 | 0 | 2 |
| Lidocaine Jelly for Pain Control During Mohs Surgery | 27.3 | 0 | 2 |
| Utility of Digital Dermoscopy in the Skin Cancer Clinic | 27.3 | 0 | 2 |
| Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Clinical Diagnosis of Basal Cell Carcinoma Subtype | 27.3 | 0 | 2 |
| Pilot Study of PDL to Treat BCC and SCCIS | 27.3 | 0 | 2 |
| Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC) | 27.3 | 0 | 2 |
| Skin cancer precursor immunotherapy for squamous cell carcinoma prevention | 27.3 | 0 | 2 |
| Oral lichen planus and other confounding factors in narrow band imaging (NBI) during routine inspection of oral cavity for early detection of oral squamous cell carcinoma: a retrospective pilot study | 27.3 | 0 | 2 |
| Total Body Photography and Sequential Digital Dermoscopy in Pregnant Women | 27.3 | 0 | 2 |
| Total Body Skin Examination Practices: A Survey Study Amongst Dermatologists at High-Risk Skin Cancer Clinics | 27.3 | 0 | 2 |
| A Distinct Epidemiological Pattern of Precancerous Lesions of Esophageal Squamous Cell Carcinoma in a High-Risk Area of Huai'an,Jiangsu Province,China | 27.3 | 0 | 2 |
| The association between counseling, sun protection, and early detection of skin cancer in middle-aged Israelis | 27.3 | 0 | 2 |
| Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers | 27.3 | 0 | 2 |
| Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis | 27.3 | 0 | 2 |
| T-Cadherin Expression in Actinic Keratosis Transforming to Invasive Squamous Cell Carcinoma | 27.3 | 0 | 2 |
| Topical Green Tea Ointment in Treatment of Superficial Skin Cancer | 27.3 | 0 | 2 |
| Precancerous Lesions of Squamous Cell Carcinoma of the Cervix: Squamous Dysplasia | 27.3 | 0 | 2 |
| Nanocytology Test to Evaluate Skin Cancer in High Risk Patients | 27.3 | 0 | 2 |
| Basal Cell Carcinoma Recurrence After Mohs Surgery | 27.3 | 0 | 2 |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer | 27.3 | 0 | 2 |
| Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer | 27.3 | 0 | 2 |
| Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma. | 27.3 | 0 | 2 |
| Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma | 27.3 | 0 | 2 |
| total body photography | 27.3 | 0 | 2 |
| Transient Infrared Imaging for Early Detection of Skin Cancer | 27.3 | 0 | 2 |
| A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma | 27.3 | 0 | 2 |
| The Impact of Total Body Skin Examination on Skin Cancer Detection | 27.3 | 0 | 2 |
| Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia | 27.3 | 0 | 2 |
| Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Early Detection of Skin Cancer With Sensor Technology | 27.3 | 0 | 2 |
| Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear | 27.3 | 0 | 2 |
| Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer | 27.3 | 0 | 2 |
| Imiquimod Cream in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Isotretinoin in Preventing Skin Cancer | 27.3 | 0 | 2 |
| Eflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Keratosis | 27.3 | 0 | 2 |
| Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer | 27.3 | 0 | 2 |
| Preoperative Acetaminophen and Carbohydrate Loading | 27.3 | 0 | 2 |
| A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp | 27.3 | 0 | 2 |
| DUSA: Cyclic PDT for the Prevention of AK & NMSC in Solid Organ Transplant Recipients | 27.3 | 0 | 2 |
| (Cost)-Effectiveness of Optical Coherence Tomography (OCT) in Basal Cell Carcinoma (BCC) | 27.3 | 0 | 2 |
| Electronic Brachytherapy (eBx)-Mohs Matched Pair - Cohort Study A Multi-Center Retrospective-Prospective Matched Pairs Cohort Study to Assess Long-term Clinical Outcomes of Non-melanoma Skin Cancer Patients Treated With eBx Compared to Non-melan | 27.3 | 0 | 2 |
| Pembrolizumab in Patients With Locally Advanced or Metastatic Skin Cancer | 27.3 | 0 | 2 |
| Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma | 27.3 | 0 | 2 |
| Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer | 27.3 | 0 | 2 |
| Oral precancerous lesions & early detection of oral cancer | 27.3 | 0 | 2 |
| Reflectance Confocal Microscopy in Basal Cell Carcinoma | 27.3 | 0 | 2 |
| Dysplastic nevi and the dysplastic nevus syndrome | 27.3 | 0 | 2 |
| Prevention and early detection of skin cancer/melanoma | 27.3 | 0 | 2 |
| Clinical usefulness of serum squamous cell carcinoma antigen for early detection of squamous cell carcinoma arising in mature cystic teratoma of the ovary | 27.3 | 0 | 2 |
| Recognition of skin cancers: skin cancer awareness programs in Ohio | 27.3 | 0 | 2 |
| Behavior and attitude regarding skin cancer prevention and early detection in relation to current knowledge--studies of visitors to an industrial fair | 27.3 | 0 | 2 |
| Basal cell carcinoma among the cases of Dermatology Clinic I of the Silesian Medical Academy in Katowice | 27.3 | 0 | 2 |
| New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up | 27.3 | 0 | 2 |
| Management of superficial squamous cell carcinoma of the lip with Mohs micrographic surgery | 27.3 | 0 | 2 |
| Morphological studies on basal cell carcinoma and squamous cell carcinoma in vitro (author's transl) | 27.3 | 0 | 2 |
| Mohs surgery report: an approach to cutaneous surgical defects of forehead and eyebrow following Mohs micrographic surgery | 27.3 | 0 | 2 |
| Subungual squamous cell carcinoma treated by Mohs surgery in a patient with sarcoidosis | 27.3 | 0 | 2 |
| Dysplastic nevi and germ cell tumors of the testis--a possible further tumor in the spectrum of associated malignancies in dysplastic nevus syndrome | 27.3 | 0 | 2 |
| Human papillomavirus (HPV) DNA sequences in oral precancerous lesions and squamous cell carcinoma demonstrated by in situ hybridization | 27.3 | 0 | 2 |
| Distribution of fibronectin and laminin in basal cell carcinoma and squamous cell carcinoma | 27.3 | 0 | 2 |
| Dysplastic nevi: markers for increased risk for melanoma | 27.3 | 0 | 2 |
| [The dermatophytic flora surveyed at the Dermatology Clinic of the Tottori University Hospital from 1981 to 1984--statistic analysis of the patients of various clinical types and a comparative study of the ratios of T. rubrum/T. mentagrophytes at de | 27.3 | 0 | 2 |
| Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas | 27.3 | 0 | 2 |
| Early detection of skin cancer. Dealing with tomorrow's problems today | 27.3 | 0 | 2 |
| Epithelial skin cancers and precancerous lesions. Epidemiology, etiology (occupational etiologies inclusive), pathologic anatomy, diagnosis, prognosis, principles of the treatment | 27.3 | 0 | 2 |
| Fluctuation of ELISA and skin biopsy results in individual inhabitants re-examined after several months in the endemic area of Guatemalan onchocerciasis | 27.3 | 0 | 2 |
| Dermatology Nurses' Association position statement on prevention and early detection of skin cancer | 27.3 | 0 | 2 |
| The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in postradiotherapy patients | 27.3 | 0 | 2 |
| Use of scintillation scanning for the early detection of bone involvement by squamous cell carcinoma of the oral mucosa: preliminary report | 27.3 | 0 | 2 |
| Reevaluation of precancerous lesion of squamous cell carcinoma | 27.3 | 0 | 2 |
| Prevention and early detection strategies for melanoma and skin cancer. Current status | 27.3 | 0 | 2 |
| Quantitative analysis of oncogene ras P21 expression in oral precancerous lesion and squamous cell carcinoma | 27.3 | 0 | 2 |
| Expression of p53 gene protein in squamous cell carcinoma and precancerous lesion of vulva | 27.3 | 0 | 2 |
| Skin cancer prevention, early detection, and management: current beliefs and practices of Australian family physicians | 27.3 | 0 | 2 |
| Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma | 27.3 | 0 | 2 |
| Aneuploidy in actinic keratosis and Bowen's disease—increased risk for invasive squamous cell carcinoma? | 27.3 | 0 | 2 |
| Skin cancer prevention and early detection practices in a sample of rural women | 27.3 | 0 | 2 |
| Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: Role of solar radiation in the pathogenesis of atypical moles | 27.3 | 0 | 2 |
| Lack of selective attendance of participants at skin cancer/melanoma screening clinics | 27.3 | 0 | 2 |
| Early detection of skin cancer. Knowledge, perceptions and practices of general practitioners in Victoria | 27.3 | 0 | 2 |
| Squamous cell carcinoma, basal cell carcinoma | 27.3 | 0 | 2 |
| 20-methylcholanthrene induced mouse skin cancer. Part 4: Study on the similarity between mouse skin cancer and human non-cicatric squamous cell carcinoma (author's transl) | 27.3 | 0 | 2 |
| Skin cancer control in Australia. The balance between primary prevention and early detection | 27.3 | 0 | 2 |
| Stereological analysis in oral precancerous lesions and squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising from chronic osteomyelitis treated by Mohs micrographic surgery | 27.3 | 0 | 2 |
| Selective loss of chondroitin 6-sulphate from basement membrane during progression from actinic keratosis to squamous cell carcinoma | 27.3 | 0 | 2 |
| Relations between basal cell carcinoma and actinic keratosis | 27.3 | 0 | 2 |
| Sunlight exposure, pigmentation factors, and risk of nonmelanocytic skin cancer. II. Squamous cell carcinoma | 27.3 | 0 | 2 |
| Dermatology Nurses' Association position statement on prevention and early detection of skin cancer | 27.3 | 0 | 2 |
| Dysplastic nevi as a melanoma risk factor in patients with familial melanoma | 27.3 | 0 | 2 |
| Dermatology Nurses' Association position statement on prevention and early detection of skin cancer | 27.3 | 0 | 2 |
| Squamous cell carcinoma and basal cell carcinoma | 27.3 | 0 | 2 |
| Mohs surgery for basal cell carcinoma on the face | 27.3 | 0 | 2 |
| Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer | 27.3 | 0 | 2 |
| Metastatic cutaneous squamous cell carcinoma derived from actinic keratosis | 27.3 | 0 | 2 |
| Actinic keratosis is squamous cell carcinoma | 27.3 | 0 | 2 |
| Squamous cell carcinoma arising in osteomyelitis and chronic wounds. Treatment with Mohs micrographic surgery vs amputation | 27.3 | 0 | 2 |
| Early melanoma detection. Skin cancer screening must become an insurance covered procedure | 27.3 | 0 | 2 |
| Status of residual tumor in patients with squamous cell carcinoma referred for Mohs micrographic surgery | 27.3 | 0 | 2 |